We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 8 for:    S1400

Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

This study is currently recruiting participants.
Verified November 2017 by Southwest Oncology Group
Sponsor:
ClinicalTrials.gov Identifier:
NCT02154490
First Posted: June 3, 2014
Last Update Posted: November 24, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
  Purpose
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid ?Master Protocol? (S1400). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes a ?non-match? sub-study which will include all screened patients not eligible for any of the biomarker-driven sub-studies. This sub-study will compare a non-match therapy to standard of care also with the goal of approval.

Condition Intervention Phase
Recurrent Squamous Cell Lung Carcinoma Stage IV Squamous Cell Lung Carcinoma AJCC v7 Drug: Docetaxel Biological: Durvalumab Drug: Erlotinib Hydrochloride Drug: FGFR Inhibitor AZD4547 Biological: Ipilimumab Other: Laboratory Biomarker Analysis Biological: Nivolumab Drug: Palbociclib Other: Pharmacological Study Biological: Rilotumumab Drug: Talazoparib Drug: Taselisib Biological: Tremelimumab Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Lung-Map)

Resource links provided by NLM:


Further study details as provided by Southwest Oncology Group:

Primary Outcome Measures:
  • Investigator-assessed progression-free survival as defined by Response Evaluation Criteria in Solid Tumors 1.1 (Design #1, Phase II) [ Time Frame: From date of sub-study registration to date of first documentation of progression assessed by local review or symptomatic deterioration, or death due to any cause, assessed up to 18 months since completion of accrual ]
    A stratified (using randomization stratification factors) log-rank test will be used to test the primary hypotheses related to investigator-assessed progression-free survival, comparing the two treatment arms.

  • Investigator-assessed progression-free survival in patients with advanced stage refractory squamous cell carcinoma of the lung randomized to receive investigational therapy vs standard therapy (Design #2,Phase III,Option for Biomarker-driven sub-studies) [ Time Frame: Up to 3 years ]
    Estimated using the method of Kaplan-Meier. The Brookmeyer-Crowley method will be used to calculate confidence intervals for median investigator-assessed progression-free survival. A stratified (using randomization stratification factors) log-rank test will be used to test the primary hypotheses related to progression free survival comparing the two treatment arms at the levels specified.

  • Less than 33% improvement in median investigator-assessed progression-free survival as defined as Response Evaluation Criteria in Solid Tumors 1.1 (Design #1, Phase III) [ Time Frame: From date of sub-study registration to date of first documentation of progression assessed by local review or symptomatic deterioration, or death due to any cause, assessed up to 18 months since completion of accrual ]
    A stratified (using randomization stratification factors) log-rank test will be used to test the primary hypotheses related to investigator-assessed progression-free survival, comparing the two treatment arms. A Cox PH model will be used to estimate the hazard ratios and associated confidence intervals.

  • Objective response rate (confirmed and unconfirmed, complete and partial) (Design #2, Phase II, Option for Biomarker-driven Sub-studies) [ Time Frame: Up to 3 years ]
    The investigational therapy arm will be judged to have provided sufficient evidence to proceed to the Phase III component if the objective response rate is at least 25%. Response rates and associated confidence intervals will be calculated.

  • Objective response rate (confirmed and unconfirmed, complete and partial) in patients treated with investigational non-match therapy with advanced stage refractory squamous cell carcinoma of the lung (Design #2, Option for Non-Match Sub-Studies) [ Time Frame: Up to 3 years ]
    Response rates and associated confidence intervals will be calculated.

  • Overall survival (Design #1, Phase III) [ Time Frame: From date of sub-study registration (or date of screening registration if patient never enrolls in a sub-study) to date of death due to any cause, assessed up to 3 years ]
    A stratified (using randomization stratification factors) log-rank test will be used to test the primary hypotheses related to overall survival, comparing the two treatment arms. A Cox PH model will be used to estimate the hazard ratios and associated confidence intervals.

  • Overall survival in patients with advanced stage refractory squamous cell carcinoma of the lung randomized to receive investigational therapy versus standard therapy (Design #2, Phase III, Option for Biomarker-driven Sub-studies) [ Time Frame: Up to 3 years ]
    The Brookmeyer-Crowley method will be used to calculate confidence intervals for median overall survival. A stratified (using randomization stratification factors) log-rank test will be used to test the primary hypotheses related to overall survival comparing the two treatment arms at the levels specified.


Secondary Outcome Measures:
  • Duration of response among patients who achieve a complete response or partial response by Response Evaluation Criteria in Solid Tumors 1.1 (Design #2, Phase II, Option for Biomarker-driven Sub-studies and Design #2, Option for Non-Match Sub-studies) [ Time Frame: Up to 3 years ]
    Estimated using the method of Kaplan-Meier. The Brookmeyer-Crowley method will be used to calculate confidence intervals for median duration of response.

  • Frequency and severity of toxicities associated with investigational therapy versus standard therapy (Design #2, Phase III, Option for Biomarker-driven Sub-studies) [ Time Frame: Up to 3 years ]
    Analysis of toxicities will be performed using a chi-square or Fisher?s exact test, as appropriate.

  • Investigator-assessed progression-free survival, censoring patients with symptomatic deterioration at the time of symptomatic deterioration (Design #1, Phase III) [ Time Frame: From date of sub-study registration to date of first documentation of progression assessed by local review or symptomatic deterioration, or death due to any cause, assessed up to 3 years ]
    Descriptive data will be presented.

  • Overall survival with investigational therapy (Design #2, Phase II, Option for Biomarker-driven Sub-studies and Design #2, Option for Non-Match Sub-studies) [ Time Frame: Up to 3 years ]
    A stratified (using randomization stratification factors) log-rank test will be used to test the primary hypotheses related to overall survival comparing the two treatment arms at the levels specified. A Cox PH model will be used to estimate the hazard ratios and associated confidence intervals.

  • Progression free survival with investigational therapy (Design #2, Phase II, Option for Biomarker-driven Sub-studies and Design #2, Option for Non-Match Sub-studies) [ Time Frame: Up to 3 years ]
    A stratified (using randomization stratification factors) log-rank test will be used to test the primary hypotheses related to progression free survival comparing the two treatment arms at the levels specified. A Cox PH model will be used to estimate the hazard ratios and associated confidence intervals.

  • Response rate (confirmed and unconfirmed) in patients with measurable disease as defined by Response Evaluation Criteria in Solid Tumors 1.1 (Design #1, Phase II and III) [ Time Frame: Up to 3 years ]
    Analysis will be performed using a chi squared or Fisher?s exact test, as appropriate. Response proportions will be compared using a 1-sided Fisher?s exact test at the 0.001 level.

  • Response rates (confirmed and unconfirmed, complete and partial) among patients randomized to receive investigational therapy versus standard therapy (Design #2, Phase III, Option for Biomarker-driven Sub-studies) [ Time Frame: Up to 3 years ]
    Analysis of response rates will be performed using a chi-square or Fisher?s exact test, as appropriate.

  • Severity of toxicities associated with investigational therapy versus standard therapy (Design #2, Phase II, Option for Biomarker-driven Sub-studies and Design #2, Option for Non-Match Sub-studies) [ Time Frame: Up to 3 years ]
    Analysis of toxicities will be performed using a chi-square or Fisher?s exact test, as appropriate.

  • Toxicity frequencies, monitored using National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0 (Design #1, Phase II and III) [ Time Frame: Up to 3 years ]
    Analysis will be performed using a chi squared or Fisher?s exact test, as appropriate.


Other Outcome Measures:
  • Screen success rate, monitored by the percentage of screened patients that register to a therapeutic sub-study [ Time Frame: Up to 3 years ]
    Descriptive data will be presented.

  • Treatment arm randomization acceptance rate, monitored by the percentage of patients that receive at least one dose of the treatment they are randomized to (Design #1) [ Time Frame: Up to 3 years ]
    Descriptive data will be presented.


Estimated Enrollment: 10000
Actual Study Start Date: June 16, 2014
Estimated Study Completion Date: April 1, 2022
Estimated Primary Completion Date: April 1, 2022 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: S1400A Arm I (MEDI4736) (CLOSED TO ACCRUAL 12/2015)
Patients with tumors that do not match one of the currently active drug-biomarker combinations randomized to Arm I receive anti-B7H1 monoclonal antibody MEDI4736 IV over 60 minutes on day 1. Treatment repeats every 14 days for 12 months in the absence of disease progression or unacceptable toxicity.
Biological: Durvalumab
Given IV
Other Names:
  • Imfinzi
  • Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer
  • MEDI-4736
  • MEDI4736
Other: Laboratory Biomarker Analysis
Correlative studies
Active Comparator: S1400A Arm II (CLOSED TO ACCRUAL 4/2015)
Patients with tumors that do not match one of the currently active drug-biomarker combinations randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #2 4/22/15)
Drug: Docetaxel
Given IV
Other Names:
  • Docecad
  • RP56976
  • Taxotere
  • Taxotere Injection Concentrate
Other: Laboratory Biomarker Analysis
Correlative studies
Experimental: S1400A Arm III (MEDI4736)
For patients assigned to Arm 1, MEDI4736: Upon evidence of progression following discontinuation of 12 months of treatment, patients may restart treatment with Arm 3, MEDI4736 for up to 12 months with the same treatment guidelines followed during the initial 12-month treatment period. Patients will only be able to restart treatment once; thus a maximum of two 12- month periods will be allowed. Patients registered to Arm III receive durvalumab IV over 60 minutes on day 1. Treatment repeats every 14 days for 12 months in the absence of disease progression or unacceptable toxicity.
Biological: Durvalumab
Given IV
Other Names:
  • Imfinzi
  • Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer
  • MEDI-4736
  • MEDI4736
Other: Laboratory Biomarker Analysis
Correlative studies
Experimental: S1400B Arm I (taselisib) (CLOSED TO ACCRUAL 12/12/2016)
Patients with tumors positive for PI3KCA randomized to Arm I receive taselisib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Other: Laboratory Biomarker Analysis
Correlative studies
Drug: Taselisib
Given PO
Other Name: GDC-0032
Active Comparator: S1400B Arm II (CLOSED TO ACCRUAL 12/18/2015)
Patients with tumors positive for PI3KCA randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)
Drug: Docetaxel
Given IV
Other Names:
  • Docecad
  • RP56976
  • Taxotere
  • Taxotere Injection Concentrate
Other: Laboratory Biomarker Analysis
Correlative studies
Experimental: S1400B Arm III (taselisib) (CLOSED TO ACCRUAL 12/12/2016)
Re-Registration Treatment with GDC-0032 (Taselisib). Upon progression patients in Arm 2 may be eligible for Re-Registration to receive GDC-0032. Patients will receive taselisib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Other: Laboratory Biomarker Analysis
Correlative studies
Drug: Taselisib
Given PO
Other Name: GDC-0032
Experimental: S1400C Arm I (palbociclib)
Patients with tumors positive for CDK4/6, CCND1, CCND2, and CCND3 randomized to Arm I receive palbociclib PO on days 1-21. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Laboratory Biomarker Analysis
Correlative studies
Drug: Palbociclib
Given PO
Other Names:
  • Ibrance
  • PD-0332991
  • PD-332991
Active Comparator: S1400C Arm II (CLOSED TO ACCRUAL 12/18/2015)
Patients with tumors positive for CDK4, CCND1, CCND2, and CCND3 randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)
Drug: Docetaxel
Given IV
Other Names:
  • Docecad
  • RP56976
  • Taxotere
  • Taxotere Injection Concentrate
Other: Laboratory Biomarker Analysis
Correlative studies
Experimental: S1400C Arm III (palbociclib)
Re-Registration Treatment with palbociclib. Upon progression patients in Arm 2 may be eligible for Re-Registration to receive palbociclib. Patients will receive palbociclib PO on days 1-21. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Laboratory Biomarker Analysis
Correlative studies
Drug: Palbociclib
Given PO
Other Names:
  • Ibrance
  • PD-0332991
  • PD-332991
Experimental: S1400D Arm I (AZD4547) (CLOSED TO ACCRUAL 04/12/2017)
Patients with tumors positive for FGFR1, FGFR2, and FGFR3 randomized to Arm I receive FGFR inhibitor AZD4547 PO BID on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Drug: FGFR Inhibitor AZD4547
Given PO
Other Name: AZD4547
Other: Laboratory Biomarker Analysis
Correlative studies
Active Comparator: S1400D Arm II (CLOSED TO ACCRUAL 10/31/2016)
Patients with tumors positive for FGFR1, FGFR2, and FGFR3 randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)
Drug: Docetaxel
Given IV
Other Names:
  • Docecad
  • RP56976
  • Taxotere
  • Taxotere Injection Concentrate
Other: Laboratory Biomarker Analysis
Correlative studies
Experimental: S1400D Arm III (AZD4547) (CLOSED TO ACCRUAL 10/31/2016)
Re-Registration Treatment with AZD4547. Upon progression patients in Arm 2 may be eligible for Re-Registration to receive AZD4547. Patients will receive FGFR inhibitor AZD4547 PO BID on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Drug: FGFR Inhibitor AZD4547
Given PO
Other Name: AZD4547
Other: Laboratory Biomarker Analysis
Correlative studies
Experimental: S1400E Arm I (CLOSED TO ACCRUAL 11/2014)
Patients with tumors positive for HGF/c-MET randomized to Arm I receive rilotumumab IV on day 1 and erlotinib hydrochloride PO daily. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (permanently closed to accrual on 11/25/14)
Drug: Erlotinib Hydrochloride
Given PO
Other Names:
  • Cp-358,774
  • OSI-774
  • Tarceva
Other: Laboratory Biomarker Analysis
Correlative studies
Biological: Rilotumumab
Given IV
Other Names:
  • AMG 102
  • Anti-HGF Monoclonal Antibody AMG 102
  • Fully Human Anti-HGF Monoclonal Antibody AMG 102
Active Comparator: S1400E Arm II (CLOSED TO ACCRUAL 11/2014)
Patients with tumors positive for HGF/c-MET randomized to Arm II receive erlotinib hydrochloride PO daily. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (permanently closed to accrual on 11/25/14)
Drug: Erlotinib Hydrochloride
Given PO
Other Names:
  • Cp-358,774
  • OSI-774
  • Tarceva
Other: Laboratory Biomarker Analysis
Correlative studies
Experimental: S1400F (durvalumab, tremelimumab)
Patients with disease progression during or after prior anti-PD-1 or anti-PD-L1 antibody monotherapy as their most recent line of treatment receive durvalumab (IV over 60 minutes) and tremelimumab (IV over 60 minutes) on day 1 for courses 1-4 and durvalumab IV alone on day 1 of course 5 and subsequent courses until disease progression or unacceptable toxicity. Courses repeat every 28 days.
Biological: Durvalumab
Given IV
Other Names:
  • Imfinzi
  • Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer
  • MEDI-4736
  • MEDI4736
Other: Laboratory Biomarker Analysis
Correlative studies
Other: Pharmacological Study
Correlative studies
Biological: Tremelimumab
Given IV
Other Names:
  • Anti-CTLA4 Human Monoclonal Antibody CP-675,206
  • CP-675
  • CP-675,206
  • CP-675206
  • ticilimumab
Experimental: S1400G (talazoparib)
Patients with tumors positive for homologous recombination repair deficiency receive talazoparib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Other: Laboratory Biomarker Analysis
Correlative studies
Other: Pharmacological Study
Correlative studies
Drug: Talazoparib
Given PO
Other Names:
  • BMN 673
  • BMN-673
Experimental: S1400I Arm I (nivolumab, ipilimumab)
Patients with tumors that do not match one of the currently active drug-biomarker combinations or did not meet the eligibility requirements for that bio-marker driven sub-study randomized to Arm I receive nivolumab IV over 30 minutes on day 1 and ipilimumab IV over 60 minutes on day 1 of every third cycle. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.
Biological: Ipilimumab
Given IV
Other Names:
  • Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody
  • BMS-734016
  • MDX-010
  • MDX-CTLA4
  • Yervoy
Other: Laboratory Biomarker Analysis
Correlative studies
Biological: Nivolumab
Given IV
Other Names:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
Active Comparator: S1400I Arm II (nivolumab)
Patients with tumors that do not match one of the currently active drug-biomarker combinations or did not meet the eligibility requirements for that bio-marker driven sub-study randomized to Arm II receive nivolumab IV over 30 minutes on day 1. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.
Other: Laboratory Biomarker Analysis
Correlative studies
Biological: Nivolumab
Given IV
Other Names:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
Other: Pharmacological Study
Correlative studies

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • SCREENING/PRE-SCREENING REGISTRATION:
  • Patients must have pathologically proven squamous cell carcinoma (SCCA) cancer of the lung confirmed by tumor biopsy and/or fine-needle aspiration; disease must be stage IV SCCA, or recurrent; the primary diagnosis of SCCA should be established using the current World Health Organization (WHO)/International Association for the Study of Lung Cancer (IASLC)-classification of Thoracic Malignancies; the diagnosis is based on hematoxylin and eosin (H&E) stained slides with or without specific defined immunohistochemistry (IHC) characteristic (p40/p63 positive, transcription termination factor [TTF1] negative) if required for diagnosis; mixed histologies are not allowed
  • Patients must either be eligible to be screened at progression on prior treatment or to be pre-screened prior to progression on current treatment; patients will either consent to the screening consent or the pre-screening consent, not both; these criteria are:

    • Screening at progression on prior treatment: to be eligible for screening at progression, patients must have received at least one line of systemic therapy for any stage of disease (stages I-IV) and must have progressed during or following their most recent line of therapy; for patients whose prior systemic therapy was for stage I-III disease only (i.e. patient has not received any treatment for stage IV or recurrent disease), the prior systemic therapy must have been a platinum-based chemotherapy regimen and disease progression on the platinum-based chemotherapy must have occurred within one year from the last date that patient received that therapy; for patients whose prior therapy was for stage IV or recurrent disease, the patient must have received at least one line of a platinum-based chemotherapy regimen or checkpoint inhibitor therapy (e.g. nivolumab or pembrolizumab)
    • Pre-screening prior to progression on current treatment: to be eligible for pre-screening, current treatment must be for stage IV or recurrent disease and patient must have received at least one dose of the current regimen; patients must have previously received or currently be receiving a platinum-based chemotherapy regimen or checkpoint inhibitor therapy (e.g. nivolumab or pembrolizumab); patients on first-line platinum-based treatment are eligible upon receiving cycle 1, day 1 infusion; Note: patients will not receive their sub-study assignment until they progress and the S1400 Notice of Progression is submitted
  • Patients must have adequate tumor tissue available, defined as >= 20% tumor cells and >= 0.2 mm^3 tumor volume

    • The local interpreting pathologist must review the specimen
    • The pathologist must sign the S1400 Local Pathology Review Form confirming tissue adequacy prior to screening/pre-screening registration
    • Patients must agree to have this tissue submitted to Foundation Medicine for common broad platform Clinical Laboratory Improvement Act (CLIA) biomarker profiling; if archival tumor material is exhausted, then a new fresh tumor biopsy that is formalin-fixed and paraffin-embedded (FFPE) must be obtained; a tumor block or FFPE slides 4-5 microns thick must be submitted; bone biopsies are not allowed; if FFPE slides are to be submitted, at least 12 unstained slides plus an H&E stained slide, or 13 unstained slides must be submitted; however it is strongly recommended that 20 FFPE slides be submitted; Note: previous next-generation deoxyribonucleic acid (DNA) sequencing (NGS) will be repeated if done outside this study for sub-study assignment; patients must agree to have any tissue that remains after NGS testing retained for the use of the translational medicine (TM) studies (if such TM studies are defined) within any sub-study the patient is enrolled in
  • Patients must not have a known epidermal growth factor receptor (EGFR) mutation or anaplastic lymphoma kinase (ALK) fusion; EGFR/ALK testing is not required prior to registration and is included in the Foundation Medicine Incorporated (FMI) testing for screening/prescreening
  • Patients must have Zubrod performance status 0-1 documented within 28 days prior to screening/pre-screening registration
  • Patients must also be offered participation in banking for future use of specimens
  • Patients must be willing to provide prior smoking history as required on the S1400 Onstudy Form
  • As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
  • Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
  • SUB-STUDY REGISTRATION:
  • Patients whose biomarker profiling results indicate the presence of an EGFR mutation or echinoderm microtubule-associated protein-like 4 (EML4)/ALK fusion are not eligible
  • Patients must have progressed (in the opinion of the treating investigator) following the most recent line of therapy
  • Patients must not have received any prior systemic therapy (systemic chemotherapy, immunotherapy or investigational drug) within 21 days prior to sub-study registration; patients must have recovered (=< grade 1) from any side effects of prior therapy; patients must not have received any radiation therapy within 14 days prior to sub-study registration
  • Patients must have measurable disease documented by computed tomography (CT) or magnetic resonance imaging (MRI); the CT from a combined positron emission tomography (PET)/CT may be used to document only non-measurable disease unless it is of diagnostic quality; measurable disease must be assessed within 28 days prior to sub-study registration; pleural effusions, ascites and laboratory parameters are not acceptable as the only evidence of disease; non-measurable disease must be assessed within 42 days prior to sub-study registration; all disease must be assessed and documented on the Baseline Tumor Assessment Form; patients whose only measurable disease is within a previous radiation therapy port must demonstrate clearly progressive disease (in the opinion of the treating investigator) prior to registration
  • Patients must have a CT or MRI scan of the brain to evaluate for central nervous system (CNS) disease within 42 days prior to sub-study registration; patient must not have leptomeningeal disease, spinal cord compression or brain metastases unless: (1) metastases have been locally treated and have remained clinically controlled and asymptomatic for at least 14 days following treatment and prior to registration, AND (2) patient has no residual neurological dysfunction and has been off corticosteroids for at least 24 hours prior to sub-study registration
  • Patient must have fully recovered from the effects of prior surgery at least 14 days prior to sub-study registration
  • Patients must not be planning to receive any concurrent chemotherapy, immunotherapy, biologic or hormonal therapy for cancer treatment; concurrent use of hormones for non-cancer-related conditions (e.g., insulin for diabetes and hormone replacement therapy) is acceptable
  • Absolute neutrophil count (ANC) >= 1,500/mcl obtained within 28 days prior to sub-study registration
  • Platelet count >= 100,000 mcl obtained within 28 days prior to sub-study registration
  • Hemoglobin >= 9 g/dL obtained within 28 days prior to sub-study registration
  • Serum bilirubin =< institutional upper limit of normal (IULN) within 28 days prior to sub-study registration; for patients with liver metastases, bilirubin must be =< 5 x IULN
  • Either alanine aminotransferase (ALT) or aspartate aminotransferase (AST) =< 2 x IULN within 28 days prior to sub-study registration (if both ALT and AST are done, both must be =< 2 IULN); for patients with liver metastases, either ALT or AST must be =< 5 x IULN (if both ALT and AST are done, both must be =< 5 x IULN)
  • Serum creatinine =< the IULN OR measured or calculated creatinine clearance >= 50 mL/min using the following Cockcroft-Gault Formula within 28 days prior to sub-study registration
  • Patients must have Zubrod performance status 0-1 documented within 28 days prior to sub-study registration
  • Patients must not have any grade III/IV cardiac disease as defined by the New York Heart Association Criteria (i.e., patients with cardiac disease resulting in marked limitation of physical activity or resulting in inability to carry on any physical activity without discomfort), unstable angina pectoris, and myocardial infarction within 6 months, or serious uncontrolled cardiac arrhythmia
  • Patients must not have documented evidence of acute hepatitis or have an active or uncontrolled infection
  • Patients with a known history of human immunodeficiency virus (HIV) seropositivity:

    • Must have undetectable viral load using standard HIV assays in clinical practice
    • Must have cluster of differentiation (CD)4 count >= 400/mcL
    • Must not require prophylaxis for any opportunistic infections (i.e., fungal, Mycobacterium avium complex [mAC], or pneumocystis jiroveci pneumonia [PCP] prophylaxis)
    • Must not be newly diagnosed within 12 months prior to sub-study registration
  • Prestudy history and physical exam must be obtained within 28 days prior to sub-study registration
  • No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for five years
  • Patients must not be pregnant or nursing; women/men of reproductive potential must have agreed to use an effective contraceptive method; a woman is considered to be of "reproductive potential" if she has had menses at any time in the preceding 12 consecutive months; in addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation; however, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures
  • As part of the OPEN registration process the treating institution?s identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered into the system
  • Patients with impaired decision-making capacity are eligible as long as their neurological or psychological condition does not preclude their safe participation in the study (e.g., tracking pill consumption and reporting adverse events to the investigator)
  • Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02154490


  Hide Study Locations
Locations
United States, Alabama
University of Alabama at Birmingham Cancer Center Recruiting
Birmingham, Alabama, United States, 35233
Contact: Francisco Robert       protocols@swog.org   
Principal Investigator: Francisco Robert         
United States, Alaska
Anchorage Associates in Radiation Medicine Recruiting
Anchorage, Alaska, United States, 98508
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Alaska Breast Care and Surgery LLC Recruiting
Anchorage, Alaska, United States, 99508
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Alaska Oncology and Hematology LLC Recruiting
Anchorage, Alaska, United States, 99508
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Alaska Regional Hospital Suspended
Anchorage, Alaska, United States, 99508
Anchorage Oncology Centre Recruiting
Anchorage, Alaska, United States, 99508
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Katmai Oncology Group Recruiting
Anchorage, Alaska, United States, 99508
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Providence Alaska Medical Center Recruiting
Anchorage, Alaska, United States, 99508
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Fairbanks Memorial Hospital Recruiting
Fairbanks, Alaska, United States, 99701
Contact: John A. Keech    907-458-5380      
Principal Investigator: John A. Keech         
United States, Arizona
University of Arizona Cancer Center-North Campus Recruiting
Tucson, Arizona, United States, 85719
Contact: Linda L. Garland    520-626-9008      
Principal Investigator: Linda L. Garland         
The University of Arizona Medical Center-University Campus Recruiting
Tucson, Arizona, United States, 85724
Contact: Linda L. Garland    520-626-9008      
Principal Investigator: Linda L. Garland         
United States, Arkansas
Mercy Cancer Center-Hot Springs Suspended
Hot Springs, Arkansas, United States, 71913
Fowler Family Center for Cancer Care Recruiting
Jonesboro, Arkansas, United States, 72401
Contact: Carroll D. Scroggin    870-936-7000      
Principal Investigator: Carroll D. Scroggin         
University of Arkansas for Medical Sciences Recruiting
Little Rock, Arkansas, United States, 72205
Contact: Konstantinos Arnaoutakis    501-686-8274      
Principal Investigator: Konstantinos Arnaoutakis         
United States, California
Kaiser Permanente-Anaheim Recruiting
Anaheim, California, United States, 92807
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Kaiser Permanente-Deer Valley Medical Center Suspended
Antioch, California, United States, 94531
Sutter Auburn Faith Hospital Recruiting
Auburn, California, United States, 95602
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
AIS Cancer Center at San Joaquin Community Hospital Suspended
Bakersfield, California, United States, 93301
Kaiser Permanente-Baldwin Park Recruiting
Baldwin Park, California, United States, 91706
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Kaiser Permanente-Bellflower Recruiting
Bellflower, California, United States, 90706
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Alta Bates Summit Medical Center-Herrick Campus Suspended
Berkeley, California, United States, 94704
Mills-Peninsula Medical Center Recruiting
Burlingame, California, United States, 94010
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
City of Hope Corona Suspended
Corona, California, United States, 92879
City of Hope Comprehensive Cancer Center Recruiting
Duarte, California, United States, 91010
Contact: Marianna Koczywas    800-826-4673    becomingapatient@coh.org   
Principal Investigator: Marianna Koczywas         
Kaiser Permanente Hospital Recruiting
Fontana, California, United States, 92335
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Kaiser Permanente-Fremont Suspended
Fremont, California, United States, 94538
Palo Alto Medical Foundation-Fremont Recruiting
Fremont, California, United States, 94538
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Washington Hospital Suspended
Fremont, California, United States, 94538
Kaiser Permanente Suspended
Fresno, California, United States, 93720
Saint Jude Medical Center Suspended
Fullerton, California, United States, 92835
Kaiser Permanente - Harbor City Recruiting
Harbor City, California, United States, 90710
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Kaiser Permanente-Irvine Recruiting
Irvine, California, United States, 92618
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
UC San Diego Moores Cancer Center Recruiting
La Jolla, California, United States, 92093
Contact: Lyudmila A. Bazhenova    858-822-5354    cancercto@ucsd.edu   
Principal Investigator: Lyudmila A. Bazhenova         
City of Hope Antelope Valley Suspended
Lancaster, California, United States, 93534
Loma Linda University Medical Center Recruiting
Loma Linda, California, United States, 92354
Contact: Hamid R. Mirshahidi    909-558-3375      
Principal Investigator: Hamid R. Mirshahidi         
Kaiser Permanente Los Angeles Medical Center Recruiting
Los Angeles, California, United States, 90027
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Los Angeles County-USC Medical Center Suspended
Los Angeles, California, United States, 90033
USC / Norris Comprehensive Cancer Center Suspended
Los Angeles, California, United States, 90033
Kaiser Permanente-Cadillac Recruiting
Los Angeles, California, United States, 90034
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Fremont - Rideout Cancer Center Suspended
Marysville, California, United States, 95901
Memorial Medical Center Suspended
Modesto, California, United States, 95355
Kaiser Permanente-Modesto Suspended
Modesto, California, United States, 95356
Community Hospital of Monterey Peninsula Suspended
Monterey, California, United States, 93940
Pacific Cancer Care-Monterey Suspended
Monterey, California, United States, 93940
Palo Alto Medical Foundation-Camino Division Suspended
Mountain View, California, United States, 94040
Palo Alto Medical Foundation-Gynecologic Oncology Suspended
Mountain View, California, United States, 94040
Sutter Cancer Research Consortium Recruiting
Novato, California, United States, 94945
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Kaiser Permanente-Oakland Recruiting
Oakland, California, United States, 94611
Contact: Louis Fehrenbacher    626-564-3455      
Principal Investigator: Louis Fehrenbacher         
Saint Joseph Hospital - Orange Recruiting
Orange, California, United States, 92868
Contact: Timothy E. Byun    714-734-6220      
Principal Investigator: Timothy E. Byun         
Palo Alto Medical Foundation Health Care Recruiting
Palo Alto, California, United States, 94301
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Stanford Cancer Institute Palo Alto Recruiting
Palo Alto, California, United States, 94304
Contact: Heather A. Wakelee    800-455-0057      
Principal Investigator: Heather A. Wakelee         
Kaiser Permanente - Panorama City Recruiting
Panorama City, California, United States, 91402
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Feather River Cancer Center Recruiting
Paradise, California, United States, 95969
Contact: Sam Mazj    530-876-7995    haleew@ah.org   
Principal Investigator: Sam Mazj         
PCR Oncology Suspended
Pismo Beach, California, United States, 93449
City of Hope Rancho Cucamonga Suspended
Rancho Cucamonga, California, United States, 91730
Eisenhower Medical Center Recruiting
Rancho Mirage, California, United States, 92270
Contact: Constantin A. Dasanu    760-834-3798      
Principal Investigator: Constantin A. Dasanu         
Kaiser Permanente-Redwood City Suspended
Redwood City, California, United States, 94063
Kaiser Permanente-Richmond Suspended
Richmond, California, United States, 94801
Kaiser Permanente-Riverside Recruiting
Riverside, California, United States, 92505
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Kaiser Permanente-Roseville Suspended
Roseville, California, United States, 95661
Sutter Roseville Medical Center Recruiting
Roseville, California, United States, 95661
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Sutter Medical Center Sacramento Recruiting
Sacramento, California, United States, 95816
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
University of California Davis Comprehensive Cancer Center Recruiting
Sacramento, California, United States, 95817
Contact: David R. Gandara    916-734-3089      
Principal Investigator: David R. Gandara         
Kaiser Permanente-South Sacramento Suspended
Sacramento, California, United States, 95823
Kaiser Permanente - Sacramento Suspended
Sacramento, California, United States, 95825
Saint Helena Hospital Recruiting
Saint Helena, California, United States, 94574
Contact: Gregory B. Smith    707-967-3698      
Principal Investigator: Gregory B. Smith         
Kaiser Permanente-San Diego Mission Recruiting
San Diego, California, United States, 92108
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Kaiser Permanente-San Diego Zion Recruiting
San Diego, California, United States, 92120
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
California Pacific Medical Center-Pacific Campus Suspended
San Francisco, California, United States, 94115
Kaiser Permanente-San Francisco Suspended
San Francisco, California, United States, 94115
Kaiser Permanente-Santa Teresa-San Jose Suspended
San Jose, California, United States, 95119
Kaiser Permanente San Leandro Suspended
San Leandro, California, United States, 94577
Kaiser Permanente-San Marcos Recruiting
San Marcos, California, United States, 92069
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Kaiser Permanente-San Rafael Suspended
San Rafael, California, United States, 94903
Kaiser Permanente Medical Center - Santa Clara Suspended
Santa Clara, California, United States, 95051
Palo Alto Medical Foundation-Santa Cruz Recruiting
Santa Cruz, California, United States, 95065
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Kaiser Permanente-Santa Rosa Suspended
Santa Rosa, California, United States, 95403
Kaiser Permanente-South San Francisco Suspended
South San Francisco, California, United States, 94080
Kaiser Permanente-Stockton Suspended
Stockton, California, United States, 95210
Palo Alto Medical Foundation-Sunnyvale Recruiting
Sunnyvale, California, United States, 94086
Contact: Ari D. Baron    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Ari D. Baron         
Gene Upshaw Memorial Tahoe Forest Cancer Center Suspended
Truckee, California, United States, 96161
Northbay Cancer Center Recruiting
Vacaville, California, United States, 95687
Contact: Brian G. Vikstrom    707-624-8007      
Principal Investigator: Brian G. Vikstrom         
Kaiser Permanente Medical Center-Vacaville Suspended
Vacaville, California, United States, 95688
Kaiser Permanente-Vallejo Recruiting
Vallejo, California, United States, 94589
Contact: Louis Fehrenbacher    626-564-3455      
Principal Investigator: Louis Fehrenbacher         
Sutter Solano Medical Center/Cancer Center Suspended
Vallejo, California, United States, 94589
Kaiser Permanente-Walnut Creek Suspended
Walnut Creek, California, United States, 94596
Presbyterian Intercommunity Hospital Recruiting
Whittier, California, United States, 90602
Contact: Lisa S. Wang    562-698-0811      
Principal Investigator: Lisa S. Wang         
Kaiser Permanente Recruiting
Woodland Hills, California, United States, 91367
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
United States, Colorado
University of Colorado Hospital Recruiting
Aurora, Colorado, United States, 80045
Contact: Mark R. Hancock    720-848-0650      
Principal Investigator: Mark R. Hancock         
Rocky Mountain Cancer Centers-Boulder Suspended
Boulder, Colorado, United States, 80304
Penrose-Saint Francis Healthcare Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Rocky Mountain Cancer Centers-Penrose Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Memorial Hospital Central Recruiting
Colorado Springs, Colorado, United States, 80909
Contact: Mark R. Hancock    720-848-0650      
Principal Investigator: Mark R. Hancock         
Kaiser Permanente-Franklin Suspended
Denver, Colorado, United States, 80205
SCL Health Saint Joseph Hospital Suspended
Denver, Colorado, United States, 80218
Colorado Cancer Research Program NCORP Recruiting
Denver, Colorado, United States, 80222
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Comprehensive Cancer Care and Research Institute of Colorado LLC Suspended
Englewood, Colorado, United States, 80113
Poudre Valley Hospital Recruiting
Fort Collins, Colorado, United States, 80524
Contact: Mark R. Hancock    720-848-0650      
Principal Investigator: Mark R. Hancock         
Kaiser Permanente-Rock Creek Suspended
Lafayette, Colorado, United States, 80026
Kaiser Permanente-Lone Tree Suspended
Lone Tree, Colorado, United States, 80124
Rocky Mountain Cancer Centers-Sky Ridge Suspended
Lone Tree, Colorado, United States, 80124
Sky Ridge Medical Center Suspended
Lone Tree, Colorado, United States, 80124
Longmont United Hospital Suspended
Longmont, Colorado, United States, 80501
Rocky Mountain Cancer Centers-Longmont Suspended
Longmont, Colorado, United States, 80501
McKee Medical Center Suspended
Loveland, Colorado, United States, 80539
Parker Adventist Hospital Suspended
Parker, Colorado, United States, 80138
Rocky Mountain Cancer Centers-Parker Suspended
Parker, Colorado, United States, 80138
United States, Connecticut
Danbury Hospital Suspended
Danbury, Connecticut, United States, 06810
Smilow Cancer Hospital-Derby Care Center Suspended
Derby, Connecticut, United States, 06418
Medical Oncology and Hematology Group PC-Guilford Suspended
Guilford, Connecticut, United States, 06437
Hartford Hospital Recruiting
Hartford, Connecticut, United States, 06102
Contact: Wylie D. Hosmer    860-224-5660      
Principal Investigator: Wylie D. Hosmer         
Smilow Cancer Hospital Care Center at Saint Francis Recruiting
Hartford, Connecticut, United States, 06105
Contact: Roy S. Herbst    203-785-5702      
Principal Investigator: Roy S. Herbst         
Midstate Medical Center Suspended
Meriden, Connecticut, United States, 06451
The Hospital of Central Connecticut Recruiting
New Britain, Connecticut, United States, 06050
Contact: Wylie D. Hosmer    860-224-5660      
Principal Investigator: Wylie D. Hosmer         
Smilow Cancer Center/Yale-New Haven Hospital Suspended
New Haven, Connecticut, United States, 06510
Yale University Recruiting
New Haven, Connecticut, United States, 06520
Contact: Roy S. Herbst    203-785-5702      
Principal Investigator: Roy S. Herbst         
Yale-New Haven Hospital North Haven Medical Center Suspended
North Haven, Connecticut, United States, 06473
Eastern Connecticut Hematology and Oncology Associates Suspended
Norwich, Connecticut, United States, 06360
Smilow Cancer Hospital-Orange Care Center Suspended
Orange, Connecticut, United States, 06477
Charlotte Hungerford Hospital Center for Cancer Care Suspended
Torrington, Connecticut, United States, 06790
Smilow Cancer Hospital-Waterbury Care Center Suspended
Waterbury, Connecticut, United States, 06708
Veterans Affairs Connecticut Healthcare System-West Haven Campus Recruiting
West Haven, Connecticut, United States, 06516
Contact: Herta H. Chao    203-937-3421 ext 2832      
Principal Investigator: Herta H. Chao         
United States, Delaware
Beebe Medical Center Suspended
Lewes, Delaware, United States, 19958
Delaware Clinical and Laboratory Physicians PA Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Helen F Graham Cancer Center Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Medical Oncology Hematology Consultants PA Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Regional Hematology and Oncology PA Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Christiana Care Health System-Christiana Hospital Recruiting
Newark, Delaware, United States, 19718
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Beebe Health Campus Recruiting
Rehoboth Beach, Delaware, United States, 19971
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Nanticoke Memorial Hospital Recruiting
Seaford, Delaware, United States, 19973
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Christiana Care Health System-Wilmington Hospital Recruiting
Wilmington, Delaware, United States, 19801
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
United States, District of Columbia
MedStar Georgetown University Hospital Suspended
Washington, District of Columbia, United States, 20007
Sibley Memorial Hospital Suspended
Washington, District of Columbia, United States, 20016
United States, Florida
Mount Sinai Comprehensive Cancer Center at Aventura Recruiting
Aventura, Florida, United States, 33180
Contact: Michael A. Schwartz    305-674-2625    info@msccop.com   
Principal Investigator: Michael A. Schwartz         
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Suspended
Deerfield Beach, Florida, United States, 33442
University of Florida Health Science Center ?? Gainesville Suspended
Gainesville, Florida, United States, 32610
Memorial Regional Hospital/Joe DiMaggio Children's Hospital Recruiting
Hollywood, Florida, United States, 33021
Contact: Robert A. Hirsch    954-265-4325      
Principal Investigator: Robert A. Hirsch         
UM Sylvester Comprehensive Cancer Center at Hollywood Suspended
Hollywood, Florida, United States, 33021
Mount Sinai Medical Center Recruiting
Miami Beach, Florida, United States, 33140
Contact: Michael A. Schwartz    305-674-2625    info@msccop.com   
Principal Investigator: Michael A. Schwartz         
University of Miami Miller School of Medicine-Sylvester Cancer Center Suspended
Miami, Florida, United States, 33136
Memorial Hospital West Recruiting
Pembroke Pines, Florida, United States, 33028
Contact: Robert A. Hirsch    954-265-4325      
Principal Investigator: Robert A. Hirsch         
Sacred Heart Hospital Suspended
Pensacola, Florida, United States, 32504
UM Sylvester Comprehensive Cancer Center at Plantation Suspended
Plantation, Florida, United States, 33324
Moffitt Cancer Center Recruiting
Tampa, Florida, United States, 33612
Contact: Jhanelle E. Gray    800-456-7121    canceranswers@moffitt.org   
Principal Investigator: Jhanelle E. Gray         
United States, Georgia
Phoebe Putney Memorial Hospital Recruiting
Albany, Georgia, United States, 31701
Contact: Sharad A. Ghamande    706-721-1663    cancer@augusta.edu   
Principal Investigator: Sharad A. Ghamande         
Emory University Hospital Midtown Recruiting
Atlanta, Georgia, United States, 30308
Contact: Taofeek K. Owonikoko    404-489-9164      
Principal Investigator: Taofeek K. Owonikoko         
Piedmont Hospital Active, not recruiting
Atlanta, Georgia, United States, 30309
Emory University/Winship Cancer Institute Recruiting
Atlanta, Georgia, United States, 30322
Contact: Taofeek K. Owonikoko    404-489-9164      
Principal Investigator: Taofeek K. Owonikoko         
Northside Hospital Recruiting
Atlanta, Georgia, United States, 30342
Contact: Rodolfo E. Bordoni    404-303-3355      
Principal Investigator: Rodolfo E. Bordoni         
Saint Joseph's Hospital of Atlanta Recruiting
Atlanta, Georgia, United States, 30342
Contact: Taofeek K. Owonikoko    404-489-9164      
Principal Investigator: Taofeek K. Owonikoko         
Augusta University Medical Center Suspended
Augusta, Georgia, United States, 30912
John B Amos Cancer Center Recruiting
Columbus, Georgia, United States, 31904
Contact: Andrew W. Pippas    706-660-6404      
Principal Investigator: Andrew W. Pippas         
Northside Hospital-Forsyth Suspended
Cumming, Georgia, United States, 30041
Dekalb Medical Center Recruiting
Decatur, Georgia, United States, 30033
Contact: Sharad A. Ghamande    706-721-1663    cancer@augusta.edu   
Principal Investigator: Sharad A. Ghamande         
Northeast Georgia Medical Center-Gainesville Recruiting
Gainesville, Georgia, United States, 30501
Contact: Charles H. Nash    770-219-8800    cancerpatient.navigator@nghs.com   
Principal Investigator: Charles H. Nash         
Gwinnett Medical Center Recruiting
Lawrenceville, Georgia, United States, 30045
Contact: Aldemar Montero    678-312-2666      
Principal Investigator: Aldemar Montero         
Medical Center of Central Georgia Suspended
Macon, Georgia, United States, 31201
Memorial University Medical Center Suspended
Savannah, Georgia, United States, 31404
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Recruiting
Savannah, Georgia, United States, 31405
Contact: Howard A. Zaren    912-819-5704      
Principal Investigator: Howard A. Zaren         
South Georgia Medical Center/Pearlman Cancer Center Recruiting
Valdosta, Georgia, United States, 31602
Contact: Samuel N. Ofori    229-259-4628    maryann.heddon@sgmc.org   
Principal Investigator: Samuel N. Ofori         
United States, Hawaii
Hawaii Oncology Inc-Pali Momi Recruiting
'Aiea, Hawaii, United States, 96701
Contact: Jeffrey L. Berenberg    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
Pali Momi Medical Center Recruiting
'Aiea, Hawaii, United States, 96701
Contact: Jeffrey L. Berenberg    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
The Cancer Center of Hawaii-Leeward Suspended
'Ewa Beach, Hawaii, United States, 96706
Hawaii Cancer Care Inc-POB II Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Oncology Inc-POB I Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
Queen's Medical Center Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
Straub Clinic and Hospital Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
University of Hawaii Cancer Center Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Cancer Care Inc-Liliha Recruiting
Honolulu, Hawaii, United States, 96817
Contact: Jeffrey L. Berenberg    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Oncology Inc-Kuakini Recruiting
Honolulu, Hawaii, United States, 96817
Contact: Jeffrey L. Berenberg    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
Kuakini Medical Center Suspended
Honolulu, Hawaii, United States, 96817
The Cancer Center of Hawaii-Liliha Suspended
Honolulu, Hawaii, United States, 96817
Kaiser Permanente Moanalua Medical Center Recruiting
Honolulu, Hawaii, United States, 96819
Contact: Louis Fehrenbacher    626-564-3455      
Principal Investigator: Louis Fehrenbacher         
Kapiolani Medical Center for Women and Children Recruiting
Honolulu, Hawaii, United States, 96826
Contact: Jeffrey L. Berenberg    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
United States, Idaho
Saint Alphonsus Cancer Care Center-Boise Recruiting
Boise, Idaho, United States, 83706
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Saint Luke's Mountain States Tumor Institute Recruiting
Boise, Idaho, United States, 83712
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Kootenai Medical Center Recruiting
Coeur d'Alene, Idaho, United States, 83814
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Saint Luke's Mountain States Tumor Institute - Fruitland Recruiting
Fruitland, Idaho, United States, 83619
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Saint Luke's Mountain States Tumor Institute - Meridian Recruiting
Meridian, Idaho, United States, 83642
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Saint Luke's Mountain States Tumor Institute - Nampa Recruiting
Nampa, Idaho, United States, 83686
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Kootenai Cancer Center Recruiting
Post Falls, Idaho, United States, 83854
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Kootenai Cancer Clinic Recruiting
Sandpoint, Idaho, United States, 83864
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Saint Luke's Mountain States Tumor Institute-Twin Falls Recruiting
Twin Falls, Idaho, United States, 83301
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
United States, Illinois
Rush - Copley Medical Center Suspended
Aurora, Illinois, United States, 60504
Saint Joseph Medical Center Suspended
Bloomington, Illinois, United States, 61701
Illinois CancerCare-Bloomington Recruiting
Bloomington, Illinois, United States, 61704
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Illinois CancerCare-Canton Recruiting
Canton, Illinois, United States, 61520
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Illinois CancerCare-Carthage Recruiting
Carthage, Illinois, United States, 62321
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Centralia Oncology Clinic Recruiting
Centralia, Illinois, United States, 62801
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Mount Sinai Hospital Medical Center Suspended
Chicago, Illinois, United States, 60608
Northwestern University Recruiting
Chicago, Illinois, United States, 60611
Contact: Young K. Chae    312-695-1301    cancer@northwestern.edu   
Principal Investigator: Young K. Chae         
John H Stroger Jr Hospital of Cook County Suspended
Chicago, Illinois, United States, 60612
Rush University Medical Center Suspended
Chicago, Illinois, United States, 60612
Swedish Covenant Hospital Suspended
Chicago, Illinois, United States, 60625
University of Chicago Comprehensive Cancer Center Suspended
Chicago, Illinois, United States, 60637
Carle on Vermilion Recruiting
Danville, Illinois, United States, 61832
Contact: Yujie Zhao    630-978-6212    Cancer.Research@rushcopley.com   
Principal Investigator: Yujie Zhao         
Cancer Care Center of Decatur Recruiting
Decatur, Illinois, United States, 62526
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Decatur Memorial Hospital Recruiting
Decatur, Illinois, United States, 62526
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Carle Physician Group-Effingham Recruiting
Effingham, Illinois, United States, 62401
Contact: Yujie Zhao    630-978-6212    Cancer.Research@rushcopley.com   
Principal Investigator: Yujie Zhao         
Crossroads Cancer Center Recruiting
Effingham, Illinois, United States, 62401
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Advocate Sherman Hospital Suspended
Elgin, Illinois, United States, 60123
AMITA Health Alexian Brothers Medical Center Recruiting
Elk Grove Village, Illinois, United States, 60007
Contact: Bruce B. Bank    847-952-7164    fredianc@alexian.net   
Principal Investigator: Bruce B. Bank         
Illinois CancerCare-Eureka Recruiting
Eureka, Illinois, United States, 61530
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
NorthShore University HealthSystem-Evanston Hospital Recruiting
Evanston, Illinois, United States, 60201
Contact: Thomas A. Hensing    847-570-2109      
Principal Investigator: Thomas A. Hensing         
Saint Francis Hospital Suspended
Evanston, Illinois, United States, 60202
Illinois CancerCare-Galesburg Recruiting
Galesburg, Illinois, United States, 61401
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Western Illinois Cancer Treatment Center Suspended
Galesburg, Illinois, United States, 61401
Northwestern Medicine Cancer Center Delnor Suspended
Geneva, Illinois, United States, 60134
NorthShore University HealthSystem-Glenbrook Hospital Recruiting
Glenview, Illinois, United States, 60026
Contact: Thomas A. Hensing    847-570-2109      
Principal Investigator: Thomas A. Hensing         
Ingalls Memorial Hospital Recruiting
Harvey, Illinois, United States, 60426
Contact: Mark F. Kozloff    773-834-7424      
Principal Investigator: Mark F. Kozloff         
NorthShore University HealthSystem-Highland Park Hospital Recruiting
Highland Park, Illinois, United States, 60035
Contact: Thomas A. Hensing    847-570-2109      
Principal Investigator: Thomas A. Hensing         
Hines Veterans Administration Hospital Recruiting
Hines, Illinois, United States, 60141
Contact: Cheryl M. Czerlanis    708-202-8387      
Principal Investigator: Cheryl M. Czerlanis         
AMITA Health Cancer Institute and Outpatient Center Recruiting
Hinsdale, Illinois, United States, 60521
Contact: Bruce B. Bank    847-952-7164    fredianc@alexian.net   
Principal Investigator: Bruce B. Bank         
Presence Saint Mary's Hospital Active, not recruiting
Kankakee, Illinois, United States, 60901
Illinois CancerCare-Kewanee Clinic Recruiting
Kewanee, Illinois, United States, 61443
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
NorthShore Hematology Oncology-Libertyville Suspended
Libertyville, Illinois, United States, 60048
Illinois CancerCare-Macomb Recruiting
Macomb, Illinois, United States, 61455
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Carle Physician Group-Mattoon/Charleston Recruiting
Mattoon, Illinois, United States, 61938
Contact: Yujie Zhao    630-978-6212    Cancer.Research@rushcopley.com   
Principal Investigator: Yujie Zhao         
Loyola University Medical Center Suspended
Maywood, Illinois, United States, 60153
Trinity Medical Center Suspended
Moline, Illinois, United States, 61265
Good Samaritan Regional Health Center Suspended
Mount Vernon, Illinois, United States, 62864
Hematology Oncology Consultants Limited Recruiting
Naperville, Illinois, United States, 60540
Contact: Fariborze B. Barhamand    630-369-1501      
Principal Investigator: Fariborze B. Barhamand         
UC Comprehensive Cancer Center at Silver Cross Recruiting
New Lenox, Illinois, United States, 60451
Contact: Everett E. Vokes    773-834-7424      
Principal Investigator: Everett E. Vokes         
Illinois Cancer Specialists-Niles Suspended
Niles, Illinois, United States, 60714
University of Chicago Medicine-Orland Park Recruiting
Orland Park, Illinois, United States, 60462
Contact: Everett E. Vokes    773-834-7424      
Principal Investigator: Everett E. Vokes         
Illinois CancerCare-Ottawa Clinic Recruiting
Ottawa, Illinois, United States, 61350
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Radiation Oncology of Northern Illinois Suspended
Ottawa, Illinois, United States, 61350
Illinois CancerCare-Pekin Recruiting
Pekin, Illinois, United States, 61554
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center Suspended
Pekin, Illinois, United States, 61554
Methodist Medical Center of Illinois Suspended
Peoria, Illinois, United States, 61603
Illinois CancerCare-Peoria Recruiting
Peoria, Illinois, United States, 61615
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
OSF Saint Francis Radiation Oncology at Peoria Cancer Center Suspended
Peoria, Illinois, United States, 61615
OSF Saint Francis Medical Center Suspended
Peoria, Illinois, United States, 61637
Illinois CancerCare-Peru Recruiting
Peru, Illinois, United States, 61354
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Valley Radiation Oncology Suspended
Peru, Illinois, United States, 61354
Illinois CancerCare-Princeton Recruiting
Princeton, Illinois, United States, 61356
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Hematology Oncology Associates of Illinois - Skokie Suspended
Skokie, Illinois, United States, 60076
Central Illinois Hematology Oncology Center Suspended
Springfield, Illinois, United States, 62702
Southern Illinois University School of Medicine Recruiting
Springfield, Illinois, United States, 62702
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Springfield Clinic Recruiting
Springfield, Illinois, United States, 62702
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Memorial Medical Center Recruiting
Springfield, Illinois, United States, 62781
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Cancer Care Specialists of Illinois-Swansea Recruiting
Swansea, Illinois, United States, 62226
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Carle Cancer Center Recruiting
Urbana, Illinois, United States, 61801
Contact: Yujie Zhao    630-978-6212    Cancer.Research@rushcopley.com   
Principal Investigator: Yujie Zhao         
The Carle Foundation Hospital Recruiting
Urbana, Illinois, United States, 61801
Contact: Yujie Zhao    630-978-6212    Cancer.Research@rushcopley.com   
Principal Investigator: Yujie Zhao         
Northwestern Medicine Cancer Center Warrenville Suspended
Warrenville, Illinois, United States, 60555
Rush-Copley Healthcare Center Suspended
Yorkville, Illinois, United States, 60560
United States, Indiana
IU Health North Hospital Recruiting
Carmel, Indiana, United States, 46032
Contact: Shadia I. Jalal    888-342-7602      
Principal Investigator: Shadia I. Jalal         
Michiana Hematology Oncology PC-Elkhart Suspended
Elkhart, Indiana, United States, 46514
Indiana University/Melvin and Bren Simon Cancer Center Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Shadia I. Jalal    888-342-7602      
Principal Investigator: Shadia I. Jalal         
IU Health Methodist Hospital Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Shadia I. Jalal    888-342-7602      
Principal Investigator: Shadia I. Jalal         
Richard L. Roudebush Veterans Affairs Medical Center Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Shadia I. Jalal    888-342-7602      
Principal Investigator: Shadia I. Jalal         
Sidney and Lois Eskenazi Hospital Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Shadia I. Jalal    888-342-7602      
Principal Investigator: Shadia I. Jalal         
IU Health Central Indiana Cancer Centers-East Suspended
Indianapolis, Indiana, United States, 46219
Franciscan Health Indianapolis Recruiting
Indianapolis, Indiana, United States, 46237
Contact: Stephen E. Rubenstein    317-528-7060      
Principal Investigator: Stephen E. Rubenstein         
Springmill Medical Center Suspended
Indianapolis, Indiana, United States, 46290
IU Health Arnett Cancer Care Suspended
Lafayette, Indiana, United States, 47904
Memorial Regional Cancer Center Day Road Recruiting
Mishawaka, Indiana, United States, 46545
Contact: Thomas J. Reid    800-284-7370      
Principal Investigator: Thomas J. Reid         
Michiana Hematology Oncology PC-Mishawaka Suspended
Mishawaka, Indiana, United States, 46545
Franciscan Health Mooresville Recruiting
Mooresville, Indiana, United States, 46158
Contact: Stephen E. Rubenstein    317-528-7060      
Principal Investigator: Stephen E. Rubenstein         
The Community Hospital Recruiting
Munster, Indiana, United States, 46321
Contact: Mohamad Kassar    219-836-3349      
Principal Investigator: Mohamad Kassar         
Michiana Hematology Oncology PC-Plymouth Suspended
Plymouth, Indiana, United States, 46563
Reid Health Recruiting
Richmond, Indiana, United States, 47374
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Memorial Hospital of South Bend Recruiting
South Bend, Indiana, United States, 46601
Contact: Thomas J. Reid    800-284-7370      
Principal Investigator: Thomas J. Reid         
Michiana Hematology Oncology PC-South Bend Suspended
South Bend, Indiana, United States, 46601
Northern Indiana Cancer Research Consortium Recruiting
South Bend, Indiana, United States, 46628
Contact: Robin T. Zon    574-234-5123      
Principal Investigator: Robin T. Zon         
Union Hospital Recruiting
Terre Haute, Indiana, United States, 47804
Contact: Stephen E. Rubenstein    317-528-7060      
Principal Investigator: Stephen E. Rubenstein         
Michiana Hematology Oncology PC-Westville Suspended
Westville, Indiana, United States, 46391
United States, Iowa
Mary Greeley Medical Center Recruiting
Ames, Iowa, United States, 50010
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
McFarland Clinic PC-William R Bliss Cancer Center Recruiting
Ames, Iowa, United States, 50010
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
University of Iowa Healthcare Cancer Services Quad Cities Recruiting
Bettendorf, Iowa, United States, 52722
Contact: Muhammad Furqan    800-237-1225      
Principal Investigator: Muhammad Furqan         
McFarland Clinic PC-Boone Recruiting
Boone, Iowa, United States, 50036
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
Medical Oncology and Hematology Associates-West Des Moines Recruiting
Clive, Iowa, United States, 50325
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Mercy Cancer Center-West Lakes Recruiting
Clive, Iowa, United States, 50325
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Alegent Health Mercy Hospital Suspended
Council Bluffs, Iowa, United States, 51503
Greater Regional Medical Center Recruiting
Creston, Iowa, United States, 50801
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Genesis Medical Center - East Campus Recruiting
Davenport, Iowa, United States, 52803
Contact: George Kovach    800-446-6088    werners@genesishealth.com   
Principal Investigator: George Kovach         
Iowa Methodist Medical Center Recruiting
Des Moines, Iowa, United States, 50309
Contact: Robert J. Behrens    515-239-2621      
Principal Investigator: Robert J. Behrens         
Iowa-Wide Oncology Research Coalition NCORP Recruiting
Des Moines, Iowa, United States, 50309
Contact: Robert J. Behrens    515-282-2921      
Principal Investigator: Robert J. Behrens         
Medical Oncology and Hematology Associates-Des Moines Recruiting
Des Moines, Iowa, United States, 50309
Contact: Robert J. Behrens    515-239-2621      
Principal Investigator: Robert J. Behrens         
Broadlawns Medical Center Recruiting
Des Moines, Iowa, United States, 50314
Contact: Robert J. Behrens    515-239-2621      
Principal Investigator: Robert J. Behrens         
Medical Oncology and Hematology Associates-Laurel Recruiting
Des Moines, Iowa, United States, 50314
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Mercy Medical Center - Des Moines Recruiting
Des Moines, Iowa, United States, 50314
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Iowa Lutheran Hospital Recruiting
Des Moines, Iowa, United States, 50316
Contact: Robert J. Behrens    515-239-2621      
Principal Investigator: Robert J. Behrens         
McFarland Clinic PC-Trinity Cancer Center Recruiting
Fort Dodge, Iowa, United States, 50501
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
University of Iowa/Holden Comprehensive Cancer Center Recruiting
Iowa City, Iowa, United States, 52242
Contact: Muhammad Furqan    800-237-1225      
Principal Investigator: Muhammad Furqan         
McFarland Clinic PC-Jefferson Recruiting
Jefferson, Iowa, United States, 50129
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
McFarland Clinic PC-Marshalltown Recruiting
Marshalltown, Iowa, United States, 50158
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
Mercy Medical Center - North Iowa Suspended
Mason City, Iowa, United States, 50401
Siouxland Regional Cancer Center Recruiting
Sioux City, Iowa, United States, 51101
Contact: Donald B. Wender    712-252-0088      
Principal Investigator: Donald B. Wender         
Covenant Medical Center Suspended
Waterloo, Iowa, United States, 50702
Methodist West Hospital Recruiting
West Des Moines, Iowa, United States, 50266-7700
Contact: Robert J. Behrens    515-239-2621      
Principal Investigator: Robert J. Behrens         
Mercy Medical Center-West Lakes Recruiting
West Des Moines, Iowa, United States, 50266
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
United States, Kansas
Cancer Center of Kansas - Chanute Recruiting
Chanute, Kansas, United States, 66720
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Dodge City Recruiting
Dodge City, Kansas, United States, 67801
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - El Dorado Recruiting
El Dorado, Kansas, United States, 67042
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Newman Regional Health Suspended
Emporia, Kansas, United States, 66801
Cancer Center of Kansas - Fort Scott Recruiting
Fort Scott, Kansas, United States, 66701
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Saint Catherine Hospital Recruiting
Garden City, Kansas, United States, 67846
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Heartland Cancer Center Recruiting
Great Bend, Kansas, United States, 67530
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Saint Rose Ambulatory and Surgery Center Suspended
Great Bend, Kansas, United States, 67530
Hays Medical Center Recruiting
Hays, Kansas, United States, 67601
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Cancer Center of Kansas-Independence Recruiting
Independence, Kansas, United States, 67301
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
University of Kansas Cancer Center-West Recruiting
Kansas City, Kansas, United States, 66112
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
University of Kansas Cancer Center Recruiting
Kansas City, Kansas, United States, 66160
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Cancer Center of Kansas-Kingman Recruiting
Kingman, Kansas, United States, 67068
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Lawrence Memorial Hospital Recruiting
Lawrence, Kansas, United States, 66044
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Kansas Institute of Medicine Cancer and Blood Center Suspended
Lenexa, Kansas, United States, 66219
Minimally Invasive Surgery Hospital Suspended
Lenexa, Kansas, United States, 66219
Cancer Center of Kansas-Liberal Recruiting
Liberal, Kansas, United States, 67905
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Manhattan Recruiting
Manhattan, Kansas, United States, 66502
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - McPherson Recruiting
McPherson, Kansas, United States, 67460
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Newton Recruiting
Newton, Kansas, United States, 67114
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Olathe Medical Center Recruiting
Olathe, Kansas, United States, 66061
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Menorah Medical Center Suspended
Overland Park, Kansas, United States, 66209
University of Kansas Cancer Center-Overland Park Recruiting
Overland Park, Kansas, United States, 66210
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Saint Luke's South Hospital Suspended
Overland Park, Kansas, United States, 66213
Cancer Center of Kansas - Parsons Recruiting
Parsons, Kansas, United States, 67357
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Via Christi Hospital-Pittsburg Recruiting
Pittsburg, Kansas, United States, 66762
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Kansas City NCI Community Oncology Research Program Recruiting
Prairie Village, Kansas, United States, 66208
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Cancer Center of Kansas - Pratt Recruiting
Pratt, Kansas, United States, 67124
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Salina Recruiting
Salina, Kansas, United States, 67401
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Salina Regional Health Center Recruiting
Salina, Kansas, United States, 67401
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Cotton O'Neil Cancer Center / Stormont Vail Health Recruiting
Topeka, Kansas, United States, 66606
Contact: David E. Einspahr       protocols@swog.org   
Principal Investigator: David E. Einspahr         
Saint Francis Hospital and Medical Center - Topeka Recruiting
Topeka, Kansas, United States, 66606
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Cancer Center of Kansas - Wellington Recruiting
Wellington, Kansas, United States, 67152
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Wichita Medical Arts Tower Recruiting
Wichita, Kansas, United States, 67208
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Wichita Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Via Christi Regional Medical Center Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Wichita NCI Community Oncology Research Program Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Winfield Recruiting
Winfield, Kansas, United States, 67156
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
United States, Kentucky
King's Daughter's Medical Center Recruiting
Ashland, Kentucky, United States, 41101
Contact: David K. Goebel    888-823-5923    ctsucontact@westat.com   
Principal Investigator: David K. Goebel         
Flaget Memorial Hospital Recruiting
Bardstown, Kentucky, United States, 40004
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
Baptist Health Corbin Recruiting
Corbin, Kentucky, United States, 40701
Contact: Firas B. Badin    859-260-6425      
Principal Investigator: Firas B. Badin         
Oncology Hematology Care Inc-Crestview Suspended
Crestview Hills, Kentucky, United States, 41017
Hardin Memorial Hospital Recruiting
Elizabethtown, Kentucky, United States, 42701
Contact: Chandler H. Park    859-260-6456    micheal.stephens@BHSI.com   
Principal Investigator: Chandler H. Park         
Baptist Health Lexington Recruiting
Lexington, Kentucky, United States, 40503
Contact: Firas B. Badin    859-260-6425      
Principal Investigator: Firas B. Badin         
Saint Joseph Radiation Oncology Resource Center Suspended
Lexington, Kentucky, United States, 40504
Saint Joseph Hospital East Suspended
Lexington, Kentucky, United States, 40509
University of Kentucky/Markey Cancer Center Recruiting
Lexington, Kentucky, United States, 40536
Contact: Susanne M. Arnold    859-257-3379      
Principal Investigator: Susanne M. Arnold         
Jewish Hospital Suspended
Louisville, Kentucky, United States, 40202
Norton Hospital Pavilion and Medical Campus Suspended
Louisville, Kentucky, United States, 40202
The James Graham Brown Cancer Center at University of Louisville Suspended
Louisville, Kentucky, United States, 40202
Baptist Health Louisville Recruiting
Louisville, Kentucky, United States, 40207
Contact: Firas B. Badin    859-260-6425      
Principal Investigator: Firas B. Badin         
Norton Suburban Hospital and Medical Campus Suspended
Louisville, Kentucky, United States, 40207
Saints Mary and Elizabeth Hospital Suspended
Louisville, Kentucky, United States, 40215
Jewish Hospital Medical Center Northeast Suspended
Louisville, Kentucky, United States, 40245
Baptist Health Madisonville/Merle Mahr Cancer Center Recruiting
Madisonville, Kentucky, United States, 42431
Contact: Firas B. Badin    859-260-6425      
Principal Investigator: Firas B. Badin         
Baptist Health Paducah Recruiting
Paducah, Kentucky, United States, 42003
Contact: Firas B. Badin    859-260-6425      
Principal Investigator: Firas B. Badin         
United States, Louisiana
LSU Health Baton Rouge-North Clinic Recruiting
Baton Rouge, Louisiana, United States, 70805
Contact: Augusto C. Ochoa    504-568-2428    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
Hematology/Oncology Clinic LLP Suspended
Baton Rouge, Louisiana, United States, 70809
Louisiana Hematology Oncology Associates LLC Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Augusto C. Ochoa    504-568-2428    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
Mary Bird Perkins Cancer Center Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Augusto C. Ochoa    504-568-2428    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
Medical Oncology LLC Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Augusto C. Ochoa    504-568-2428    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
Ochsner Health Center-Summa Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Marc R. Matrana    504-842-3708      
Principal Investigator: Marc R. Matrana         
Mary Bird Cancer Center/Saint Tammany Parish Suspended
Covington, Louisiana, United States, 70433
North Shore Hematology Oncology Associates Inc Recruiting
Covington, Louisiana, United States, 70433
Contact: David S. Hanson    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Mary Bird Perkins Cancer Center/Terrebonne General Medical Center Suspended
Houma, Louisiana, United States, 70360
Oncology Center of The South Incorporated Recruiting
Houma, Louisiana, United States, 70360
Contact: David S. Hanson    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Ochsner Medical Center Kenner Suspended
Kenner, Louisiana, United States, 70065
East Jefferson General Hospital Recruiting
Metairie, Louisiana, United States, 70006
Contact: Augusto C. Ochoa    504-568-2428    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
Robert Veith MD LLC Recruiting
Metairie, Louisiana, United States, 70006
Contact: Augusto C. Ochoa    504-568-2428    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
University Health-Conway Suspended
Monroe, Louisiana, United States, 71202
Louisiana State University Health Science Center Suspended
New Orleans, Louisiana, United States, 70112
Tulane University Health Sciences Center Suspended
New Orleans, Louisiana, United States, 70112
University Medical Center New Orleans Recruiting
New Orleans, Louisiana, United States, 70112
Contact: Augusto C. Ochoa    504-568-2428    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
LSU Healthcare Network/Saint Charles Recruiting
New Orleans, Louisiana, United States, 70115
Contact: Augusto C. Ochoa    504-568-2428    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
Ochsner Medical Center Jefferson Recruiting
New Orleans, Louisiana, United States, 70121
Contact: Marc R. Matrana    504-842-3708      
Principal Investigator: Marc R. Matrana         
Louisiana State University Health Sciences Center Shreveport Suspended
Shreveport, Louisiana, United States, 71103
United States, Maine
Harold Alfond Center for Cancer Care Recruiting
Augusta, Maine, United States, 04330
Contact: Thomas H. Openshaw    207-973-4274      
Principal Investigator: Thomas H. Openshaw         
Eastern Maine Medical Center Recruiting
Bangor, Maine, United States, 04401
Contact: Thomas H. Openshaw    207-973-4274      
Principal Investigator: Thomas H. Openshaw         
Lafayette Family Cancer Center-EMMC Recruiting
Brewer, Maine, United States, 04412
Contact: Thomas H. Openshaw    207-973-4274      
Principal Investigator: Thomas H. Openshaw         
Mercy Hospital Suspended
Portland, Maine, United States, 04101
Penobscot Bay Medical Center Suspended
Rockport, Maine, United States, 04856
York Hospital Withdrawn
York, Maine, United States, 03909
United States, Maryland
University of Maryland/Greenebaum Cancer Center Recruiting
Baltimore, Maryland, United States, 21201
Contact: Dan P. Zandberg    800-888-8823      
Principal Investigator: Dan P. Zandberg         
Greater Baltimore Medical Center Recruiting
Baltimore, Maryland, United States, 21204
Contact: Mei Tang    443-849-3706      
Principal Investigator: Mei Tang         
Sinai Hospital of Baltimore Recruiting
Baltimore, Maryland, United States, 21215
Contact: Roberto F. Martinez    410-601-6120    pridgely@lifebridgehealth.org   
Principal Investigator: Roberto F. Martinez         
MedStar Union Memorial Hospital Suspended
Baltimore, Maryland, United States, 21218
Saint Agnes Hospital Suspended
Baltimore, Maryland, United States, 21229
MedStar Franklin Square Medical Center/Weinberg Cancer Institute Suspended
Baltimore, Maryland, United States, 21237
Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting
Baltimore, Maryland, United States, 21287
Contact: Julie R. Brahmer    410-955-8804    jhcccro@jhmi.edu   
Principal Investigator: Julie R. Brahmer         
Western Maryland Regional Medical Center Recruiting
Cumberland, Maryland, United States, 21502
Contact: Blanche H. Mavromatis    240-964-1400      
Principal Investigator: Blanche H. Mavromatis         
Frederick Memorial Hospital Suspended
Frederick, Maryland, United States, 21701
Northwest Hospital Center Recruiting
Randallstown, Maryland, United States, 21133
Contact: Roberto F. Martinez    410-601-6120    pridgely@lifebridgehealth.org   
Principal Investigator: Roberto F. Martinez         
Peninsula Regional Medical Center Recruiting
Salisbury, Maryland, United States, 21801
Contact: Justinian R. Ngaiza    866-922-6237      
Principal Investigator: Justinian R. Ngaiza         
William E Kahlert Regional Cancer Center/Sinai Hospital Recruiting
Westminster, Maryland, United States, 21157
Contact: Roberto F. Martinez    410-601-6120    pridgely@lifebridgehealth.org   
Principal Investigator: Roberto F. Martinez         
United States, Massachusetts
Beverly Hospital Suspended
Beverly, Massachusetts, United States, 01915
Massachusetts General Hospital Cancer Center Suspended
Boston, Massachusetts, United States, 02114
Boston Medical Center Recruiting
Boston, Massachusetts, United States, 02118
Contact: Marjory Charlot    617-638-8265      
Principal Investigator: Marjory Charlot         
Beth Israel Deaconess Medical Center Suspended
Boston, Massachusetts, United States, 02215
Lahey Hospital and Medical Center Recruiting
Burlington, Massachusetts, United States, 01805
Contact: Paul J. Hesketh    781-744-8027      
Principal Investigator: Paul J. Hesketh         
Simonds-Sinon Regional Cancer Center Recruiting
Fitchburg, Massachusetts, United States, 01420
Contact: William V. Walsh    508-856-3216    cancer.research@umassmed.edu   
Principal Investigator: William V. Walsh         
Addison Gilbert Hospital Suspended
Gloucester, Massachusetts, United States, 01930
Lowell General Hospital Suspended
Lowell, Massachusetts, United States, 01854
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Suspended
Milford, Massachusetts, United States, 01757
Dana-Farber/Brigham and Women's Cancer Center at South Shore Suspended
South Weymouth, Massachusetts, United States, 02190
Baystate Medical Center Recruiting
Springfield, Massachusetts, United States, 01199
Contact: John C. McCann    413-794-3565    tamara.wrenn@baystatehealth.org   
Principal Investigator: John C. McCann         
University of Massachusetts Medical School Recruiting
Worcester, Massachusetts, United States, 01655
Contact: William V. Walsh    508-856-3216    cancer.research@umassmed.edu   
Principal Investigator: William V. Walsh         
United States, Michigan
Hickman Cancer Center Suspended
Adrian, Michigan, United States, 49221
Veteran's Administration Medical Center - Ann Arbor Suspended
Ann Arbor, Michigan, United States, 48105
Saint Joseph Mercy Hospital Recruiting
Ann Arbor, Michigan, United States, 48106-0995
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
University of Michigan Comprehensive Cancer Center Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Gregory P. Kalemkerian    800-865-1125      
Principal Investigator: Gregory P. Kalemkerian         
Bronson Battle Creek Recruiting
Battle Creek, Michigan, United States, 49017
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
IHA Hematology Oncology Consultants-Brighton Recruiting
Brighton, Michigan, United States, 48114
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Brighton Recruiting
Brighton, Michigan, United States, 48114
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
IHA Hematology Oncology Consultants-Canton Recruiting
Canton, Michigan, United States, 48188
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Canton Health Center Recruiting
Canton, Michigan, United States, 48188
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
IHA Hematology Oncology Consultants-Chelsea Recruiting
Chelsea, Michigan, United States, 48118
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Chelsea Recruiting
Chelsea, Michigan, United States, 48118
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Hematology Oncology Consultants-Clarkston Recruiting
Clarkston, Michigan, United States, 48346
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Newland Medical Associates-Clarkston Recruiting
Clarkston, Michigan, United States, 48346
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Beaumont Hospital-Dearborn Suspended
Dearborn, Michigan, United States, 48124
Wayne State University/Karmanos Cancer Institute Recruiting
Detroit, Michigan, United States, 48201
Contact: Antoinette J. Wozniak    313-576-9363      
Principal Investigator: Antoinette J. Wozniak         
Henry Ford Hospital Recruiting
Detroit, Michigan, United States, 48202
Contact: Robert A. Chapman    313-916-1784      
Principal Investigator: Robert A. Chapman         
Saint John Hospital and Medical Center Recruiting
Detroit, Michigan, United States, 48236
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Green Bay Oncology - Escanaba Recruiting
Escanaba, Michigan, United States, 49829
Contact: Matthew L. Ryan    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Matthew L. Ryan         
Weisberg Cancer Treatment Center Recruiting
Farmington Hills, Michigan, United States, 48334
Contact: Antoinette J. Wozniak    313-576-9363      
Principal Investigator: Antoinette J. Wozniak         
Hurley Medical Center Recruiting
Flint, Michigan, United States, 48502
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Genesys Hurley Cancer Institute Recruiting
Flint, Michigan, United States, 48503
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Mercy Health Saint Mary's Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Spectrum Health at Butterworth Campus Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Allegiance Health Suspended
Jackson, Michigan, United States, 49201
Borgess Medical Center Suspended
Kalamazoo, Michigan, United States, 49001
West Michigan Cancer Center Recruiting
Kalamazoo, Michigan, United States, 49007
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Sparrow Hospital Recruiting
Lansing, Michigan, United States, 48912
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Saint Mary Mercy Hospital Recruiting
Livonia, Michigan, United States, 48154
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Mid-Michigan Medical Center - Midland Recruiting
Midland, Michigan, United States, 48670
Contact: Daniel Y. Danso    989-839-3377      
Principal Investigator: Daniel Y. Danso         
Monroe Cancer Center Recruiting
Monroe, Michigan, United States, 48162
Contact: Abhijit B. Saste    419-824-1842      
Principal Investigator: Abhijit B. Saste         
Lakeland Community Hospital Recruiting
Niles, Michigan, United States, 49120
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Assarian Cancer Center Recruiting
Novi, Michigan, United States, 48374-1236
Contact: Michael J. Kraut    248-849-5337    jaswinder.grewal@stjohn.org   
Principal Investigator: Michael J. Kraut         
Hope Cancer Center Recruiting
Pontiac, Michigan, United States, 48341
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Newland Medical Associates-Pontiac Recruiting
Pontiac, Michigan, United States, 48341
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Oakland Recruiting
Pontiac, Michigan, United States, 48341
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Lake Huron Medical Center Suspended
Port Huron, Michigan, United States, 48060
Spectrum Health Reed City Hospital Recruiting
Reed City, Michigan, United States, 49677
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
William Beaumont Hospital-Royal Oak Recruiting
Royal Oak, Michigan, United States, 48073
Contact: Michael J. Stender    248-551-7695      
Principal Investigator: Michael J. Stender         
Saint Mary's of Michigan Recruiting
Saginaw, Michigan, United States, 48601
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Lakeland Hospital Recruiting
Saint Joseph, Michigan, United States, 49085
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Marie Yeager Cancer Center Recruiting
Saint Joseph, Michigan, United States, 49085
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Providence Hospital-Southfield Cancer Center Recruiting
Southfield, Michigan, United States, 48075
Contact: Michael J. Kraut    248-849-5337    jaswinder.grewal@stjohn.org   
Principal Investigator: Michael J. Kraut         
Munson Medical Center Recruiting
Traverse City, Michigan, United States, 49684
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
William Beaumont Hospital - Troy Recruiting
Troy, Michigan, United States, 48098
Contact: Michael J. Stender    248-551-7695      
Principal Investigator: Michael J. Stender         
Saint John Macomb-Oakland Hospital Recruiting
Warren, Michigan, United States, 48093
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Metro Health Hospital Recruiting
Wyoming, Michigan, United States, 49519
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
IHA Hematology Oncology Consultants-Ann Arbor Recruiting
Ypsilanti, Michigan, United States, 48197
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
United States, Minnesota
Sanford Clinic North-Bemidgi Recruiting
Bemidji, Minnesota, United States, 56601
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Essentia Health Saint Joseph's Medical Center Suspended
Brainerd, Minnesota, United States, 56401
Fairview Ridges Hospital Suspended
Burnsville, Minnesota, United States, 55337
Mercy Hospital Recruiting
Coon Rapids, Minnesota, United States, 55433
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Essentia Health Cancer Center Recruiting
Duluth, Minnesota, United States, 55805
Contact: Bret E. Friday    888-203-7267      
Principal Investigator: Bret E. Friday         
Essentia Health Saint Mary's Medical Center Suspended
Duluth, Minnesota, United States, 55805
Miller-Dwan Hospital Suspended
Duluth, Minnesota, United States, 55805
Fairview-Southdale Hospital Recruiting
Edina, Minnesota, United States, 55435
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Lake Region Healthcare Corporation-Cancer Care Suspended
Fergus Falls, Minnesota, United States, 56537
Unity Hospital Recruiting
Fridley, Minnesota, United States, 55432
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Hutchinson Area Health Care Suspended
Hutchinson, Minnesota, United States, 55350
Minnesota Oncology Hematology PA-Maplewood Suspended
Maplewood, Minnesota, United States, 55109
Saint John's Hospital - Healtheast Recruiting
Maplewood, Minnesota, United States, 55109
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Abbott-Northwestern Hospital Recruiting
Minneapolis, Minnesota, United States, 55407
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Hennepin County Medical Center Recruiting
Minneapolis, Minnesota, United States, 55415
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Health Partners Inc Suspended
Minneapolis, Minnesota, United States, 55454
New Ulm Medical Center Suspended
New Ulm, Minnesota, United States, 56073
North Memorial Medical Health Center Recruiting
Robbinsdale, Minnesota, United States, 55422
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Mayo Clinic Suspended
Rochester, Minnesota, United States, 55905
Metro Minnesota Community Oncology Research Consortium Terminated
Saint Louis Park, Minnesota, United States, 55416
Park Nicollet Clinic - Saint Louis Park Recruiting
Saint Louis Park, Minnesota, United States, 55416
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Regions Hospital Suspended
Saint Paul, Minnesota, United States, 55101
United Hospital Suspended
Saint Paul, Minnesota, United States, 55102
Saint Francis Regional Medical Center Suspended
Shakopee, Minnesota, United States, 55379
Lakeview Hospital Suspended
Stillwater, Minnesota, United States, 55082
Ridgeview Medical Center Suspended
Waconia, Minnesota, United States, 55387
Rice Memorial Hospital Recruiting
Willmar, Minnesota, United States, 56201
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Minnesota Oncology Hematology PA-Woodbury Recruiting
Woodbury, Minnesota, United States, 55125
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
United States, Mississippi
University of Mississippi Medical Center Recruiting
Jackson, Mississippi, United States, 39216
Contact: Jennifer T. Eubanks    601-815-6700      
Principal Investigator: Jennifer T. Eubanks         
Family Cancer Center-Oxford Recruiting
Oxford, Mississippi, United States, 38655
Contact: Raymond U. Osarogiagbon    870-936-7000      
Principal Investigator: Raymond U. Osarogiagbon         
Singing River Hospital Recruiting
Pascagoula, Mississippi, United States, 39581
Contact: James E. Clarkson    228-809-5292      
Principal Investigator: James E. Clarkson         
Family Cancer Center-Southhaven Suspended
Southaven, Mississippi, United States, 38671
Baptist Memorial Hospital-Desoto Recruiting
Southhaven, Mississippi, United States, 38671
Contact: Raymond U. Osarogiagbon    870-936-7000      
Principal Investigator: Raymond U. Osarogiagbon         
United States, Missouri
Central Care Cancer Center-Carrie J Babb Cancer Center Recruiting
Bolivar, Missouri, United States, 65613
Contact: Jay W. Carlson    888-221-4849      
Principal Investigator: Jay W. Carlson         
Parkland Health Center-Bonne Terre Recruiting
Bonne Terre, Missouri, United States, 63628
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Saint Francis Medical Center Recruiting
Cape Girardeau, Missouri, United States, 63703
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Southeast Cancer Center Recruiting
Cape Girardeau, Missouri, United States, 63703
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Saint Luke's Hospital Recruiting
Chesterfield, Missouri, United States, 63017
Contact: Donald F. Busiek    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Donald F. Busiek         
University of Missouri - Ellis Fischel Suspended
Columbia, Missouri, United States, 65212
Siteman Cancer Center at West County Hospital Recruiting
Creve Coeur, Missouri, United States, 63141
Contact: Daniel Morgensztern    800-600-3606    info@siteman.wustl.edu   
Principal Investigator: Daniel Morgensztern         
Centerpoint Medical Center LLC Suspended
Independence, Missouri, United States, 64057
Capital Region Medical Center-Goldschmidt Cancer Center Recruiting
Jefferson City, Missouri, United States, 65109
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Freeman Health System Suspended
Joplin, Missouri, United States, 64804
Mercy Hospital-Joplin Recruiting
Joplin, Missouri, United States, 64804
Contact: Jay W. Carlson    888-221-4849      
Principal Investigator: Jay W. Carlson         
Truman Medical Center Recruiting
Kansas City, Missouri, United States, 64108
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Saint Luke's Hospital of Kansas City Suspended
Kansas City, Missouri, United States, 64111
Heartland Hematology and Oncology Associates Incorporated Suspended
Kansas City, Missouri, United States, 64118
Kansas City Veterans Affairs Medical Center Recruiting
Kansas City, Missouri, United States, 64128
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
The University of Kansas Cancer Center-South Recruiting
Kansas City, Missouri, United States, 64131
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Research Medical Center Suspended
Kansas City, Missouri, United States, 64132
The University of Kansas Cancer Center-North Recruiting
Kansas City, Missouri, United States, 64154
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
The University of Kansas Cancer Center-Lee's Summit Recruiting
Lee's Summit, Missouri, United States, 64064
Contact: Chao H. Huang    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Chao H. Huang         
Saint Luke's East - Lee's Summit Suspended
Lee's Summit, Missouri, United States, 64086
Liberty Radiation Oncology Center Suspended
Liberty, Missouri, United States, 64068
Delbert Day Cancer Institute at PCRMC Suspended
Rolla, Missouri, United States, 65401
Saint John's Clinic-Rolla-Cancer and Hematology Suspended
Rolla, Missouri, United States, 65401
Heartland Regional Medical Center Suspended
Saint Joseph, Missouri, United States, 64506
Saint Louis Cancer and Breast Institute-South City Suspended
Saint Louis, Missouri, United States, 63109
Washington University School of Medicine Recruiting
Saint Louis, Missouri, United States, 63110
Contact: Daniel Morgensztern    800-600-3606    info@siteman.wustl.edu   
Principal Investigator: Daniel Morgensztern         
Missouri Baptist Medical Center Recruiting
Saint Louis, Missouri, United States, 63131
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Mercy Hospital Saint Louis Recruiting
Saint Louis, Missouri, United States, 63141
Contact: Jay W. Carlson    888-221-4849      
Principal Investigator: Jay W. Carlson         
Siteman Cancer Center at Saint Peters Hospital Recruiting
Saint Peters, Missouri, United States, 63376
Contact: Daniel Morgensztern    800-600-3606    info@siteman.wustl.edu   
Principal Investigator: Daniel Morgensztern         
Sainte Genevieve County Memorial Hospital Recruiting
Sainte Genevieve, Missouri, United States, 63670
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Mercy Hospital Springfield Recruiting
Springfield, Missouri, United States, 65804
Contact: Jay W. Carlson    888-221-4849      
Principal Investigator: Jay W. Carlson         
CoxHealth South Hospital Recruiting
Springfield, Missouri, United States, 65807
Contact: Jay W. Carlson    888-221-4849      
Principal Investigator: Jay W. Carlson         
Missouri Baptist Sullivan Hospital Recruiting
Sullivan, Missouri, United States, 63080
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
Missouri Baptist Outpatient Center-Sunset Hills Recruiting
Sunset Hills, Missouri, United States, 63127
Contact: James L. Wade    309-243-3605      
Principal Investigator: James L. Wade         
United States, Montana
Community Hospital of Anaconda Recruiting
Anaconda, Montana, United States, 59711
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Billings Clinic Cancer Center Recruiting
Billings, Montana, United States, 59101
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Saint Vincent Healthcare Suspended
Billings, Montana, United States, 59101
Montana Cancer Consortium NCORP Recruiting
Billings, Montana, United States, 59102
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Bozeman Deaconess Hospital Recruiting
Bozeman, Montana, United States, 59715
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Saint James Community Hospital and Cancer Treatment Center Suspended
Butte, Montana, United States, 59701
Benefis Healthcare- Sletten Cancer Institute Recruiting
Great Falls, Montana, United States, 59405
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Great Falls Clinic Recruiting
Great Falls, Montana, United States, 59405
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Saint Peter's Community Hospital Recruiting
Helena, Montana, United States, 59601
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Kalispell Regional Medical Center Recruiting
Kalispell, Montana, United States, 59901
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Saint Patrick Hospital - Community Hospital Suspended
Missoula, Montana, United States, 59802
Community Medical Hospital Recruiting
Missoula, Montana, United States, 59804
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
United States, Nebraska
CHI Health Saint Francis Recruiting
Grand Island, Nebraska, United States, 68803
Contact: Mehmet S. Copur    501-622-2100      
Principal Investigator: Mehmet S. Copur         
CHI Health Good Samaritan Suspended
Kearney, Nebraska, United States, 68847
Nebraska Hematology and Oncology Recruiting
Lincoln, Nebraska, United States, 68506
Contact: Gamini S. Soori    402-991-8070    mwilwerding@mvcc.cc   
Principal Investigator: Gamini S. Soori         
Nebraska Cancer Research Center Suspended
Lincoln, Nebraska, United States, 68510
Saint Elizabeth Regional Medical Center Suspended
Lincoln, Nebraska, United States, 68510
Southeast Nebraska Cancer Center Recruiting
Lincoln, Nebraska, United States, 68510
Contact: Gamini S. Soori    402-991-8070    mwilwerding@mvcc.cc   
Principal Investigator: Gamini S. Soori         
Faith Regional Medical Offices West Recruiting
Norfolk, Nebraska, United States, 68701
Contact: Gamini S. Soori    402-991-8070    mwilwerding@mvcc.cc   
Principal Investigator: Gamini S. Soori         
Great Plains Regional Medical Center Recruiting
North Platte, Nebraska, United States, 69103
Contact: Gamini S. Soori    402-991-8070    mwilwerding@mvcc.cc   
Principal Investigator: Gamini S. Soori         
Missouri Valley Cancer Consortium Recruiting
Omaha, Nebraska, United States, 68106
Contact: Gamini S. Soori    402-398-6060      
Principal Investigator: Gamini S. Soori         
Nebraska Methodist Hospital Active, not recruiting
Omaha, Nebraska, United States, 68114
Alegent Health Immanuel Medical Center Suspended
Omaha, Nebraska, United States, 68122
Alegent Health Bergan Mercy Medical Center Suspended
Omaha, Nebraska, United States, 68124
Oncology Hematology West Recruiting
Omaha, Nebraska, United States, 68124
Contact: Gamini S. Soori    402-991-8070    mwilwerding@mvcc.cc   
Principal Investigator: Gamini S. Soori         
Alegent Health Lakeside Hospital Suspended
Omaha, Nebraska, United States, 68130
Creighton University Medical Center Suspended
Omaha, Nebraska, United States, 68131
University of Nebraska Medical Center Recruiting
Omaha, Nebraska, United States, 68198
Contact: Apar K. Ganti    402-559-6941    unmcrsa@unmc.edu   
Principal Investigator: Apar K. Ganti         
Midlands Community Hospital Suspended
Papillion, Nebraska, United States, 68046
Regional West Medical Center Recruiting
Scottsbluff, Nebraska, United States, 69361
Contact: Gamini S. Soori    402-991-8070    mwilwerding@mvcc.cc   
Principal Investigator: Gamini S. Soori         
United States, Nevada
Carson Tahoe Regional Medical Center Suspended
Carson City, Nevada, United States, 89703
Cancer and Blood Specialists-Henderson Suspended
Henderson, Nevada, United States, 89052
Comprehensive Cancer Centers of Nevada - Henderson Suspended
Henderson, Nevada, United States, 89052
Las Vegas Cancer Center-Henderson Suspended
Henderson, Nevada, United States, 89052
21st Century Oncology - Henderson Suspended
Henderson, Nevada, United States, 89074
Comprehensive Cancer Centers of Nevada-Southeast Henderson Suspended
Henderson, Nevada, United States, 89074
Cancer and Blood Specialists-Shadow Suspended
Las Vegas, Nevada, United States, 89106
Nevada Cancer Research Foundation CCOP Recruiting
Las Vegas, Nevada, United States, 89106
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
21st Century Oncology Suspended
Las Vegas, Nevada, United States, 89109
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway Suspended
Las Vegas, Nevada, United States, 89109
HealthCare Partners Medical Group Oncology/Hematology-San Martin Suspended
Las Vegas, Nevada, United States, 89113
Cancer Therapy and Integrative Medicine Suspended
Las Vegas, Nevada, United States, 89121
Ann M Wierman MD LTD Suspended
Las Vegas, Nevada, United States, 89128
Cancer and Blood Specialists-Tenaya Suspended
Las Vegas, Nevada, United States, 89128
Comprehensive Cancer Centers of Nevada - Northwest Suspended
Las Vegas, Nevada, United States, 89128
HealthCare Partners Medical Group Oncology/Hematology-Tenaya Suspended
Las Vegas, Nevada, United States, 89128
Summerlin Hospital Medical Center Suspended
Las Vegas, Nevada, United States, 89144
Las Vegas Cancer Center-Medical Center Suspended
Las Vegas, Nevada, United States, 89148-2405
Comprehensive Cancer Centers of Nevada Suspended
Las Vegas, Nevada, United States, 89148
Nevada Cancer Specialists-Fort Apache Suspended
Las Vegas, Nevada, United States, 89148
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills Suspended
Las Vegas, Nevada, United States, 89149
Comprehensive Cancer Centers of Nevada - Central Valley Suspended
Las Vegas, Nevada, United States, 89169
Renown Regional Medical Center Recruiting
Reno, Nevada, United States, 89502
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Alpine Hematology-Oncology Suspended
Reno, Nevada, United States, 89503
Saint Mary's Regional Medical Center Suspended
Reno, Nevada, United States, 89503
Radiation Oncology Associates Suspended
Reno, Nevada, United States, 89509
Reno Oncology Consultants Suspended
Reno, Nevada, United States, 89519
United States, New Hampshire
New Hampshire Oncology Hematology PA-Concord Recruiting
Concord, New Hampshire, United States, 03301
Contact: Douglas J. Weckstein    603-663-1800      
Principal Investigator: Douglas J. Weckstein         
New Hampshire Oncology Hematology PA-Hooksett Recruiting
Hooksett, New Hampshire, United States, 03106
Contact: Douglas J. Weckstein    603-663-1800      
Principal Investigator: Douglas J. Weckstein         
LRGHealthcare-Lakes Region General Hospital Suspended
Laconia, New Hampshire, United States, 03246
Dartmouth Hitchcock Medical Center Recruiting
Lebanon, New Hampshire, United States, 03756
Contact: Konstantin H. Dragnev    800-639-6918    cancer.research.nurse@dartmouth.edu   
Principal Investigator: Konstantin H. Dragnev         
Norris Cotton Cancer Center-Manchester Recruiting
Manchester, New Hampshire, United States, 03102
Contact: Konstantin H. Dragnev    800-639-6918    cancer.research.nurse@dartmouth.edu   
Principal Investigator: Konstantin H. Dragnev         
United States, New Jersey
Veterans Adminstration New Jersey Health Care System Suspended
East Orange, New Jersey, United States, 07018-1095
Virtua Memorial Active, not recruiting
Mount Holly, New Jersey, United States, 08060
Jersey Shore Medical Center Suspended
Neptune, New Jersey, United States, 07753
Newark Beth Israel Medical Center Suspended
Newark, New Jersey, United States, 07112
Riverview Medical Center/Booker Cancer Center Suspended
Red Bank, New Jersey, United States, 07701
Robert Wood Johnson University Hospital Somerset Recruiting
Somerville, New Jersey, United States, 08876
Contact: Steven E. Young    908-685-2481      
Principal Investigator: Steven E. Young         
Virtua Voorhees Active, not recruiting
Voorhees, New Jersey, United States, 08043
United States, New Mexico
Lovelace Medical Center-Downtown Suspended
Albuquerque, New Mexico, United States, 87102
University of New Mexico Cancer Center Recruiting
Albuquerque, New Mexico, United States, 87102
Contact: Ian Rabinowitz    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ian Rabinowitz         
New Mexico Oncology Hematology Consultants Recruiting
Albuquerque, New Mexico, United States, 87109
Contact: Ian Rabinowitz    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ian Rabinowitz         
Memorial Medical Center - Las Cruces Recruiting
Las Cruces, New Mexico, United States, 88011
Contact: Ian Rabinowitz    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ian Rabinowitz         
United States, New York
New York Oncology Hematology PC -Albany Medical Center Suspended
Albany, New York, United States, 12208
Montefiore Medical Center-Einstein Campus Recruiting
Bronx, New York, United States, 10461
Contact: Haiying Cheng    718-904-2730    aecc@aecom.yu.edu   
Principal Investigator: Haiying Cheng         
Montefiore Medical Center-Weiler Hospital Recruiting
Bronx, New York, United States, 10461
Contact: Haiying Cheng    718-904-2730    aecc@aecom.yu.edu   
Principal Investigator: Haiying Cheng         
Montefiore Medical Center - Moses Campus Recruiting
Bronx, New York, United States, 10467-2490
Contact: Haiying Cheng    718-904-2730    aecc@aecom.yu.edu   
Principal Investigator: Haiying Cheng         
Roswell Park Cancer Institute Recruiting
Buffalo, New York, United States, 14263
Contact: Hongbin Chen    877-275-7724      
Principal Investigator: Hongbin Chen         
Mary Imogene Bassett Hospital Recruiting
Cooperstown, New York, United States, 13326
Contact: Eric Bravin    607-547-3073    diana.crean@bassett.org   
Principal Investigator: Eric Bravin         
Arnot Ogden Medical Center/Falck Cancer Center Recruiting
Elmira, New York, United States, 14905
Contact: Serge Dauphin    607-271-7000      
Principal Investigator: Serge Dauphin         
Glens Falls Hospital Suspended
Glens Falls, New York, United States, 12801
Orange Regional Medical Center Suspended
Middletown, New York, United States, 10940
Beth Israel Medical Center Suspended
New York, New York, United States, 10003
Columbia University/Herbert Irving Cancer Center Recruiting
New York, New York, United States, 10032
Contact: Naiyer A. Rizvi    212-639-7202      
Principal Investigator: Naiyer A. Rizvi         
University of Rochester Suspended
Rochester, New York, United States, 14642
Stony Brook University Medical Center Recruiting
Stony Brook, New York, United States, 11794
Contact: Roger S. Keresztes    800-862-2215      
Principal Investigator: Roger S. Keresztes         
State University of New York Upstate Medical University Recruiting
Syracuse, New York, United States, 13210
Contact: Stephen L. Graziano    315-464-5476      
Principal Investigator: Stephen L. Graziano         
Faxton-Saint Luke's Healthcare Recruiting
Utica, New York, United States, 13502
Contact: Atul V. Butala    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Atul V. Butala         
United States, North Carolina
Randolph Hospital Recruiting
Asheboro, North Carolina, United States, 27203
Contact: Vinay K. Gudena    336-832-0821      
Principal Investigator: Vinay K. Gudena         
Cancer Care of Western North Carolina Suspended
Asheville, North Carolina, United States, 28801
Mission Hospital-Memorial Campus Recruiting
Asheville, North Carolina, United States, 28801
Contact: Christopher H. Chay    828-213-4150      
Principal Investigator: Christopher H. Chay         
Cone Health Cancer Center at Alamance Regional Recruiting
Burlington, North Carolina, United States, 27215
Contact: Vinay K. Gudena    336-832-0821      
Principal Investigator: Vinay K. Gudena         
Novant Health Presbyterian Medical Center Suspended
Charlotte, North Carolina, United States, 28204
Oncology Specialists of Charlotte Suspended
Charlotte, North Carolina, United States, 28207
Southern Oncology Specialists-Charlotte Suspended
Charlotte, North Carolina, United States, 28262
Southeastern Medical Oncology Center-Clinton Suspended
Clinton, North Carolina, United States, 28328
Duke University Medical Center Recruiting
Durham, North Carolina, United States, 27710
Contact: Jeffrey Crawford    888-275-3853      
Principal Investigator: Jeffrey Crawford         
Cape Fear Valley Health System Suspended
Fayetteville, North Carolina, United States, 28304
Southeastern Medical Oncology Center-Goldsboro Suspended
Goldsboro, North Carolina, United States, 27534
Wayne Memorial Hospital Suspended
Goldsboro, North Carolina, United States, 27534
Cone Health Cancer Center Recruiting
Greensboro, North Carolina, United States, 27403
Contact: Vinay K. Gudena    336-832-0821      
Principal Investigator: Vinay K. Gudena         
Hendersonville Hematology and Oncology at Pardee Suspended
Hendersonville, North Carolina, United States, 28791
Margaret R Pardee Memorial Hospital Suspended
Hendersonville, North Carolina, United States, 28791
High Point Regional Hospital Suspended
High Point, North Carolina, United States, 27262
Lake Norman Hematology Oncology Specialists-Huntersville Suspended
Huntersville, North Carolina, United States, 28078
Southern Oncology Specialists-Huntersville Suspended
Huntersville, North Carolina, United States, 28078
Southeastern Medical Oncology Center-Jacksonville Suspended
Jacksonville, North Carolina, United States, 28546
Kinston Medical Specialists PA Recruiting
Kinston, North Carolina, United States, 28501
Contact: Peter R. Watson    252-559-2200      
Principal Investigator: Peter R. Watson         
Matthews Radiation Oncology Center Suspended
Matthews, North Carolina, United States, 28105
Novant Health Cancer Specialists-Matthews Suspended
Matthews, North Carolina, United States, 28105
Lake Norman Hematology Oncology Specialists-Mooresville Suspended
Mooresville, North Carolina, United States, 28117
FirstHealth of the Carolinas-Moore Regional Hosiptal Recruiting
Pinehurst, North Carolina, United States, 28374
Contact: Charles S. Kuzma    619-532-8712      
Principal Investigator: Charles S. Kuzma         
Duke Raleigh Hospital Recruiting
Raleigh, North Carolina, United States, 27609
Contact: Jeffrey Crawford    888-275-3853      
Principal Investigator: Jeffrey Crawford         
Annie Penn Memorial Hospital Suspended
Reidsville, North Carolina, United States, 27320
Southeastern Medical Oncology Center-Wilson Suspended
Wilson, North Carolina, United States, 27893
United States, North Dakota
Sanford Bismarck Medical Center Recruiting
Bismarck, North Dakota, United States, 58501
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Roger Maris Cancer Center Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Sanford Broadway Medical Center Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Sanford Clinic North-Fargo Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Trinity Cancer Care Center Recruiting
Minot, North Dakota, United States, 58701
Contact: Stephen N. Makoni    800-862-0005      
Principal Investigator: Stephen N. Makoni         
United States, Ohio
Cleveland Clinic Cancer Center Beachwood Suspended
Beachwood, Ohio, United States, 44122
UHHS-Chagrin Highlands Medical Center Suspended
Beachwood, Ohio, United States, 44122
Strecker Cancer Center-Belpre Recruiting
Belpre, Ohio, United States, 45714
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Mercy Medical Center Recruiting
Canton, Ohio, United States, 44708
Contact: Mitchell Haut    888-293-4673      
Principal Investigator: Mitchell Haut         
Aultman Health Foundation Suspended
Canton, Ohio, United States, 44710
Geauga Hospital Suspended
Chardon, Ohio, United States, 44024
Adena Regional Medical Center Recruiting
Chillicothe, Ohio, United States, 45601
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Oncology Hematology Care Inc-Eden Park Suspended
Cincinnati, Ohio, United States, 45202
Oncology Hematology Care Inc-Mercy West Suspended
Cincinnati, Ohio, United States, 45211
University of Cincinnati/Barrett Cancer Center Recruiting
Cincinnati, Ohio, United States, 45219
Contact: John C. Morris    513-558-4553    uchealthnews@uc.edu   
Principal Investigator: John C. Morris         
Good Samaritan Hospital - Cincinnati Suspended
Cincinnati, Ohio, United States, 45220
Oncology Hematology Care Inc - Anderson Suspended
Cincinnati, Ohio, United States, 45230
Oncology Hematology Care Inc-Kenwood Suspended
Cincinnati, Ohio, United States, 45236
Bethesda North Hospital Suspended
Cincinnati, Ohio, United States, 45242
Oncology Hematology Care Inc-Blue Ash Suspended
Cincinnati, Ohio, United States, 45242
TriHealth Cancer Institute-Westside Suspended
Cincinnati, Ohio, United States, 45247
TriHealth Cancer Institute-Anderson Suspended
Cincinnati, Ohio, United States, 45255
Case Western Reserve University Suspended
Cleveland, Ohio, United States, 44106
MetroHealth Medical Center Recruiting
Cleveland, Ohio, United States, 44109
Contact: Bruce J. Averbook    216-778-8526    kbauchens@metrohealth.org   
Principal Investigator: Bruce J. Averbook         
Cleveland Clinic Cancer Center/Fairview Hospital Recruiting
Cleveland, Ohio, United States, 44111
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Cleveland Clinic Foundation Recruiting
Cleveland, Ohio, United States, 44195
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Ohio State University Comprehensive Cancer Center Recruiting
Columbus, Ohio, United States, 43210
Contact: Erin M. Bertino    800-293-5066    Jamesline@osumc.edu   
Principal Investigator: Erin M. Bertino         
Columbus Oncology and Hematology Associates Inc Recruiting
Columbus, Ohio, United States, 43214
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Riverside Methodist Hospital Recruiting
Columbus, Ohio, United States, 43214
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Columbus NCI Community Oncology Research Program Terminated
Columbus, Ohio, United States, 43215
Grant Medical Center Recruiting
Columbus, Ohio, United States, 43215
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
The Mark H Zangmeister Center Recruiting
Columbus, Ohio, United States, 43219
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Mount Carmel Health Center West Recruiting
Columbus, Ohio, United States, 43222
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Doctors Hospital Recruiting
Columbus, Ohio, United States, 43228
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Good Samaritan Hospital - Dayton Recruiting
Dayton, Ohio, United States, 45406
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Dayton Physicians LLC-Samaritan North Recruiting
Dayton, Ohio, United States, 45415
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Samaritan North Health Center Recruiting
Dayton, Ohio, United States, 45415
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Delaware Health Center-Grady Cancer Center Recruiting
Delaware, Ohio, United States, 43015
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Grady Memorial Hospital Suspended
Delaware, Ohio, United States, 43015
Mercy Cancer Center-Elyria Suspended
Elyria, Ohio, United States, 44035
Oncology Hematology Care Inc-Healthplex Suspended
Fairfield, Ohio, United States, 45014
Cleveland Clinic Cancer Center Independence Recruiting
Independence, Ohio, United States, 44131
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Kettering Medical Center Suspended
Kettering, Ohio, United States, 45429
Fairfield Medical Center Suspended
Lancaster, Ohio, United States, 43130
Cleveland Clinic Cancer Center Mansfield Recruiting
Mansfield, Ohio, United States, 44906
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Marietta Memorial Hospital Recruiting
Marietta, Ohio, United States, 45750
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Toledo Clinic Cancer Centers-Maumee Suspended
Maumee, Ohio, United States, 43537
Hillcrest Hospital Cancer Center Recruiting
Mayfield Heights, Ohio, United States, 44124
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Ireland Cancer Center Landerbrook Health Center Suspended
Mayfield Heights, Ohio, United States, 44124
Lake University Ireland Cancer Center Recruiting
Mentor, Ohio, United States, 44060
Contact: Afshin Dowlati    800-641-2422      
Principal Investigator: Afshin Dowlati         
Southwest General Health Center Ireland Cancer Center Suspended
Middleburg Heights, Ohio, United States, 44130
Knox Community Hospital Recruiting
Mount Vernon, Ohio, United States, 43050
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Licking Memorial Hospital Recruiting
Newark, Ohio, United States, 43055
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Southern Ohio Medical Center Recruiting
Portsmouth, Ohio, United States, 45662
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Ireland Cancer Center at Firelands Regional Medical Center Suspended
Sandusky, Ohio, United States, 44870
North Coast Cancer Care Recruiting
Sandusky, Ohio, United States, 44870
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Springfield Regional Medical Center Suspended
Springfield, Ohio, United States, 45505
Cleveland Clinic Cancer Center Strongsville Recruiting
Strongsville, Ohio, United States, 44136
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Flower Hospital Recruiting
Sylvania, Ohio, United States, 43560
Contact: Abhijit B. Saste    419-824-1842      
Principal Investigator: Abhijit B. Saste         
The Toledo Hospital/Toledo Children's Hospital Recruiting
Toledo, Ohio, United States, 43606
Contact: Abhijit B. Saste    419-824-1842      
Principal Investigator: Abhijit B. Saste         
University of Toledo Recruiting
Toledo, Ohio, United States, 43614
Contact: Roland T. Skeel    419-383-6583      
Principal Investigator: Roland T. Skeel         
Toledo Clinic Cancer Centers-Toledo Suspended
Toledo, Ohio, United States, 43623
Upper Valley Medical Center Suspended
Troy, Ohio, United States, 45373
University Hospitals Sharon Health Center Suspended
Wadsworth, Ohio, United States, 44281
South Pointe Hospital Suspended
Warrensville Heights, Ohio, United States, 44122
University Pointe Recruiting
West Chester, Ohio, United States, 45069
Contact: John C. Morris    513-558-4553    uchealthnews@uc.edu   
Principal Investigator: John C. Morris         
Saint Ann's Hospital Recruiting
Westerville, Ohio, United States, 43081
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
UH-Seidman Cancer Center at Saint John Medical Center Suspended
Westlake, Ohio, United States, 44145
UHHS-Westlake Medical Center Suspended
Westlake, Ohio, United States, 44145
Cleveland Clinic Wooster Family Health and Surgery Center Recruiting
Wooster, Ohio, United States, 44691
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Genesis Healthcare System Cancer Care Center Recruiting
Zanesville, Ohio, United States, 43701
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
United States, Oklahoma
Cancer Centers of Southwest Oklahoma Research Suspended
Lawton, Oklahoma, United States, 73505
University of Oklahoma Health Sciences Center Recruiting
Oklahoma City, Oklahoma, United States, 73104
Contact: Mohammad A. Razaq    405-271-8777    ou-clinical-trials@ouhsc.edu   
Principal Investigator: Mohammad A. Razaq         
Oklahoma Cancer Specialists and Research Institute-Tulsa Recruiting
Tulsa, Oklahoma, United States, 74146
Contact: Mohammad A. Razaq    405-271-8777    ou-clinical-trials@ouhsc.edu   
Principal Investigator: Mohammad A. Razaq         
United States, Oregon
Saint Charles Health System Suspended
Bend, Oregon, United States, 97701
Providence Oncology and Hematology Care Southeast Suspended
Clackamas, Oregon, United States, 97015
Bay Area Hospital Suspended
Coos Bay, Oregon, United States, 97420
Legacy Mount Hood Medical Center Recruiting
Gresham, Oregon, United States, 97030
Contact: Jacqueline Vuky    503-413-1742      
Principal Investigator: Jacqueline Vuky         
Providence Newberg Medical Center Suspended
Newberg, Oregon, United States, 97132
Providence Willamette Falls Medical Center Suspended
Oregon City, Oregon, United States, 97045
Legacy Good Samaritan Hospital and Medical Center Recruiting
Portland, Oregon, United States, 97210
Contact: Jacqueline Vuky    503-413-1742      
Principal Investigator: Jacqueline Vuky         
Providence Portland Medical Center Suspended
Portland, Oregon, United States, 97213
Providence Saint Vincent Medical Center Suspended
Portland, Oregon, United States, 97225
Kaiser Permanente Northwest Recruiting
Portland, Oregon, United States, 97227
Contact: Abdul H. Mansoor    503-335-2400      
Principal Investigator: Abdul H. Mansoor         
Oregon Health and Science University Recruiting
Portland, Oregon, United States, 97239
Contact: Jeremy P. Cetnar    503-494-1080    trials@ohsu.edu   
Principal Investigator: Jeremy P. Cetnar         
Salem Hospital Recruiting
Salem, Oregon, United States, 97301
Contact: Natasha M. Tiffany    503-561-2618      
Principal Investigator: Natasha M. Tiffany         
Legacy Meridian Park Hospital Recruiting
Tualatin, Oregon, United States, 97062
Contact: Jacqueline Vuky    503-413-1742      
Principal Investigator: Jacqueline Vuky         
United States, Pennsylvania
Lehigh Valley Hospital-Cedar Crest Recruiting
Allentown, Pennsylvania, United States, 18103
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Lehigh Valley Hospital - Muhlenberg Recruiting
Bethlehem, Pennsylvania, United States, 18017
Contact: Philip J. Stella    208-367-7954      
Principal Investigator: Philip J. Stella         
Bryn Mawr Hospital Suspended
Bryn Mawr, Pennsylvania, United States, 19010
Christiana Care Health System-Concord Health Center Recruiting
Chadds Ford, Pennsylvania, United States, 19317
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Geisinger Medical Center Recruiting
Danville, Pennsylvania, United States, 17822
Contact: Rajiv Panikkar    570-271-5251      
Principal Investigator: Rajiv Panikkar         
Ephrata Cancer Center Recruiting
Ephrata, Pennsylvania, United States, 17522
Contact: Amir Tabatabai    877-441-7957      
Principal Investigator: Amir Tabatabai         
Ephrata Community Hospital Suspended
Ephrata, Pennsylvania, United States, 17522
Adams Cancer Center Recruiting
Gettysburg, Pennsylvania, United States, 17325
Contact: Amir Tabatabai    877-441-7957      
Principal Investigator: Amir Tabatabai         
Cherry Tree Cancer Center Recruiting
Hanover, Pennsylvania, United States, 17331
Contact: Amir Tabatabai    877-441-7957      
Principal Investigator: Amir Tabatabai         
PinnacleHealth Cancer Center-Community Campus Recruiting
Harrisburg, Pennsylvania, United States, 17109
Contact: Rodney M. Jamil    717-724-6765    klitchfield@PINNACLEHEALTH.org   
Principal Investigator: Rodney M. Jamil         
Geisinger Medical Center-Cancer Center Hazleton Recruiting
Hazleton, Pennsylvania, United States, 18201
Contact: Rajiv Panikkar    570-271-5251      
Principal Investigator: Rajiv Panikkar         
Penn State Milton S Hershey Medical Center Suspended
Hershey, Pennsylvania, United States, 17033-0850
Jefferson Hospital Suspended
Jefferson Hills, Pennsylvania, United States, 15025
Sechler Family Cancer Center Recruiting
Lebanon, Pennsylvania, United States, 17042
Contact: Amir Tabatabai    877-441-7957      
Principal Investigator: Amir Tabatabai         
Geisinger Medical Oncology-Lewisburg Suspended
Lewisburg, Pennsylvania, United States, 17837
Lewistown Hospital Suspended
Lewistown, Pennsylvania, United States, 17044
Riddle Memorial Hospital Suspended
Media, Pennsylvania, United States, 19063
Forbes Hospital Suspended
Monroeville, Pennsylvania, United States, 15146
Allegheny Valley Hospital Suspended
Natrona Heights, Pennsylvania, United States, 15065
Paoli Memorial Hospital Suspended
Paoli, Pennsylvania, United States, 19301
University of Pennsylvania/Abramson Cancer Center Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Charu Aggarwal    800-474-9892      
Principal Investigator: Charu Aggarwal         
Fox Chase Cancer Center Recruiting
Philadelphia, Pennsylvania, United States, 19111
Contact: Hossein Borghaei    215-728-4790      
Principal Investigator: Hossein Borghaei         
Temple University Hospital Recruiting
Philadelphia, Pennsylvania, United States, 19140
Contact: Hossein Borghaei    215-728-4790      
Principal Investigator: Hossein Borghaei         
Allegheny General Hospital Suspended
Pittsburgh, Pennsylvania, United States, 15212
West Penn Hospital Suspended
Pittsburgh, Pennsylvania, United States, 15224
University of Pittsburgh Cancer Institute (UPCI) Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contact: Liza C. Villaruz    412-647-8073      
Principal Investigator: Liza C. Villaruz         
Pottstown Memorial Medical Center Suspended
Pottstown, Pennsylvania, United States, 19464
Geisinger Medical Oncology-Pottsville Recruiting
Pottsville, Pennsylvania, United States, 17901
Contact: Rajiv Panikkar    570-271-5251      
Principal Investigator: Rajiv Panikkar         
Penn State Health Saint Joseph Medical Center Recruiting
Reading, Pennsylvania, United States, 19605
Contact: Chandra P. Belani    717-531-3779    CTO@hmc.psu.edu   
Principal Investigator: Chandra P. Belani         
Guthrie Medical Group PC-Robert Packer Hospital Recruiting
Sayre, Pennsylvania, United States, 18840
Contact: Philip A. Lowry    800-836-0388      
Principal Investigator: Philip A. Lowry         
Community Medical Center Recruiting
Scranton, Pennsylvania, United States, 18510
Contact: Rajiv Panikkar    570-271-5251      
Principal Investigator: Rajiv Panikkar         
Geisinger Medical Oncology-Selinsgrove Suspended
Selinsgrove, Pennsylvania, United States, 17870
Geisinger Medical Group Suspended
State College, Pennsylvania, United States, 16801
Chester County Hospital Suspended
West Chester, Pennsylvania, United States, 19380
Reading Hospital Suspended
West Reading, Pennsylvania, United States, 19611
Wexford Health and Wellness Pavilion Suspended
Wexford, Pennsylvania, United States, 15090
Geisinger Wyoming Valley/Henry Cancer Center Recruiting
Wilkes-Barre, Pennsylvania, United States, 18711
Contact: Rajiv Panikkar    570-271-5251      
Principal Investigator: Rajiv Panikkar         
UPMC Susquehanna Recruiting
Williamsport, Pennsylvania, United States, 17701
Contact: Warren L. Robinson    412-647-8073      
Principal Investigator: Warren L. Robinson         
Lankenau Medical Center Suspended
Wynnewood, Pennsylvania, United States, 19096
WellSpan Health-York Cancer Center Recruiting
York, Pennsylvania, United States, 17403
Contact: Amir Tabatabai    877-441-7957      
Principal Investigator: Amir Tabatabai         
WellSpan Health-York Hospital Recruiting
York, Pennsylvania, United States, 17403
Contact: Amir Tabatabai    877-441-7957      
Principal Investigator: Amir Tabatabai         
United States, Rhode Island
Rhode Island Hospital Suspended
Providence, Rhode Island, United States, 02903
Miriam Hospital Suspended
Providence, Rhode Island, United States, 02906
United States, South Carolina
AnMed Health Cancer Center Suspended
Anderson, South Carolina, United States, 29621
Roper Hospital Suspended
Charleston, South Carolina, United States, 29401
Charleston Hematology Oncology Associates-Roper Suspended
Charleston, South Carolina, United States, 29403
Bon Secours Saint Francis Hospital Suspended
Charleston, South Carolina, United States, 29414
Charleston Hematology Oncology Associates PA-St. Francis Suspended
Charleston, South Carolina, United States, 29414
Lowcountry Hematology Oncology PA-West Ashley Suspended
Charleston, South Carolina, United States, 29414
Medical University of South Carolina Suspended
Charleston, South Carolina, United States, 29425
Greenville Health System Cancer Institute-Easley Recruiting
Easley, South Carolina, United States, 29640
Contact: Jeffrey K. Giguere    864-679-3966      
Principal Investigator: Jeffrey K. Giguere         
Gibbs Cancer Center-Gaffney Recruiting
Gaffney, South Carolina, United States, 29341
Contact: James D. Bearden    800-486-5941      
Principal Investigator: James D. Bearden         
Georgetown Hospital System Suspended
Georgetown, South Carolina, United States, 29440
Saint Francis Hospital Recruiting
Greenville, South Carolina, United States, 29601
Contact: Robert D. Siegel    864-255-1713      
Principal Investigator: Robert D. Siegel         
Greenville Health System Cancer Institute-Butternut Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey K. Giguere    864-679-3966      
Principal Investigator: Jeffrey K. Giguere         
Greenville Health System Cancer Institute-Faris Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey K. Giguere    864-679-3966      
Principal Investigator: Jeffrey K. Giguere         
Saint Francis Cancer Center Recruiting
Greenville, South Carolina, United States, 29607
Contact: Robert D. Siegel    864-255-1713      
Principal Investigator: Robert D. Siegel         
Greenville Health System Cancer Institute-Eastside Recruiting
Greenville, South Carolina, United States, 29615
Contact: Jeffrey K. Giguere    864-679-3966      
Principal Investigator: Jeffrey K. Giguere         
Gibbs Cancer Center-Pelham Recruiting
Greer, South Carolina, United States, 29651
Contact: James D. Bearden    800-486-5941      
Principal Investigator: James D. Bearden         
Lowcountry Hematology Oncology PA-Mount Pleasant Suspended
Mount Pleasant, South Carolina, United States, 29464
Greenville Health System Cancer Institute-Seneca Recruiting
Seneca, South Carolina, United States, 29672
Contact: Jeffrey K. Giguere    864-679-3966      
Principal Investigator: Jeffrey K. Giguere         
Spartanburg Medical Center Recruiting
Spartanburg, South Carolina, United States, 29303
Contact: James D. Bearden    800-486-5941      
Principal Investigator: James D. Bearden         
Greenville Health System Cancer Institute-Spartanburg Recruiting
Spartanburg, South Carolina, United States, 29307
Contact: Jeffrey K. Giguere    864-679-3966      
Principal Investigator: Jeffrey K. Giguere         
MGC Hematology Oncology-Union Suspended
Union, South Carolina, United States, 29379
Lexington Medical Center Suspended
West Columbia, South Carolina, United States, 29169
United States, South Dakota
Avera Cancer Institute-Aberdeen Suspended
Aberdeen, South Dakota, United States, 57401
Rapid City Regional Hospital Recruiting
Rapid City, South Dakota, United States, 57701
Contact: Michael O. Robinson    605-716-3982    research@rcrh.org   
Principal Investigator: Michael O. Robinson         
Sanford Cancer Center-Oncology Clinic Recruiting
Sioux Falls, South Dakota, United States, 57104
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
Avera Cancer Institute Suspended
Sioux Falls, South Dakota, United States, 57105
Sanford USD Medical Center - Sioux Falls Recruiting
Sioux Falls, South Dakota, United States, 57117-5134
Contact: Preston D. Steen    712-252-0088      
Principal Investigator: Preston D. Steen         
United States, Tennessee
Boston Baskin Cancer Center-Bartlett Suspended
Bartlett, Tennessee, United States, 38133
Cookeville Regional Medical Center Recruiting
Cookeville, Tennessee, United States, 38501
Contact: Thomas J. Summers    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Thomas J. Summers         
Vanderbilt-Ingram Cancer Center Cool Springs Recruiting
Franklin, Tennessee, United States, 37067
Contact: Sally J. York    800-811-8480      
Principal Investigator: Sally J. York         
Thompson Cancer Survival Center Recruiting
Knoxville, Tennessee, United States, 37916
Contact: Everett C. Ribakove    865-331-1812      
Principal Investigator: Everett C. Ribakove         
Thompson Cancer Survival Center - West Recruiting
Knoxville, Tennessee, United States, 37932
Contact: Everett C. Ribakove    865-331-1812      
Principal Investigator: Everett C. Ribakove         
Baptist Memorial Hospital and Cancer Center-Memphis Recruiting
Memphis, Tennessee, United States, 38120
Contact: Raymond U. Osarogiagbon    870-936-7000      
Principal Investigator: Raymond U. Osarogiagbon         
Family Cancer Center-Memphis Suspended
Memphis, Tennessee, United States, 38120
Vanderbilt Breast Center at One Hundred Oaks Recruiting
Nashville, Tennessee, United States, 37204
Contact: Sally J. York    800-811-8480      
Principal Investigator: Sally J. York         
Meharry Medical College Suspended
Nashville, Tennessee, United States, 37208
Vanderbilt University/Ingram Cancer Center Recruiting
Nashville, Tennessee, United States, 37232
Contact: Sally J. York    800-811-8480      
Principal Investigator: Sally J. York         
Thompson Oncology Group-Oak Ridge Recruiting
Oak Ridge, Tennessee, United States, 37830
Contact: Everett C. Ribakove    865-331-1812      
Principal Investigator: Everett C. Ribakove         
United States, Texas
The Don and Sybil Harrington Cancer Center Recruiting
Amarillo, Texas, United States, 79106
Contact: Anita Ravipati    806-212-1985    gcravey@harringtoncc.org   
Principal Investigator: Anita Ravipati         
Dell Seton Medical Center at The University of Texas Suspended
Austin, Texas, United States, 78701
Parkland Memorial Hospital Recruiting
Dallas, Texas, United States, 75235
Contact: Saad A. Khan    214-590-5582      
Principal Investigator: Saad A. Khan         
Baylor University Medical Center Suspended
Dallas, Texas, United States, 75246
UT Southwestern/Simmons Cancer Center-Dallas Recruiting
Dallas, Texas, United States, 75390
Contact: Saad A. Khan    214-590-5582      
Principal Investigator: Saad A. Khan         
Brooke Army Medical Center Suspended
Fort Sam Houston, Texas, United States, 78234
University of Texas Medical Branch Suspended
Galveston, Texas, United States, 77555-0565
Lyndon Baines Johnson General Hospital Suspended
Houston, Texas, United States, 77026-1967
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Recruiting
Houston, Texas, United States, 77030
Contact: Jun Zhang    713-798-1354    burton@bcm.edu   
Principal Investigator: Jun Zhang         
Ben Taub General Hospital Recruiting
Houston, Texas, United States, 77030
Contact: Jun Zhang    713-798-1354    burton@bcm.edu   
Principal Investigator: Jun Zhang         
M D Anderson Cancer Center Recruiting
Houston, Texas, United States, 77030
Contact: Vassiliki A. Papadimitrakopoulou    713-792-3245      
Principal Investigator: Vassiliki A. Papadimitrakopoulou         
Memorial Hermann Texas Medical Center Suspended
Houston, Texas, United States, 77030
Michael E DeBakey VA Medical Center Recruiting
Houston, Texas, United States, 77030
Contact: Anita L. Sabichi    713-792-3245      
Principal Investigator: Anita L. Sabichi         
The Methodist Hospital System Recruiting
Houston, Texas, United States, 77030
Contact: Eric H. Bernicker    713-790-2700      
Principal Investigator: Eric H. Bernicker         
UTMB Cancer Center at Victory Lakes Suspended
League City, Texas, United States, 77573
Covenant Medical Center-Lakeside Recruiting
Lubbock, Texas, United States, 79410
Contact: Isaac Tafur    806-725-8000    jaccresearch@covhs.org   
Principal Investigator: Isaac Tafur         
University Medical Center Recruiting
Lubbock, Texas, United States, 79415
Contact: Lukman A. Tijani    806-775-8590      
Principal Investigator: Lukman A. Tijani         
Texas Tech University Health Sciences Center-Lubbock Recruiting
Lubbock, Texas, United States, 79430
Contact: Lukman A. Tijani    806-775-8590      
Principal Investigator: Lukman A. Tijani         
University of Texas Health Science Center at San Antonio Recruiting
San Antonio, Texas, United States, 78229
Contact: Anand B. Karnad    877-469-5300      
Principal Investigator: Anand B. Karnad         
United States, Utah
American Fork Hospital / Huntsman Intermountain Cancer Center Suspended
American Fork, Utah, United States, 84003
Sandra L Maxwell Cancer Center Recruiting
Cedar City, Utah, United States, 84720
Contact: Derrick S. Haslem    801-408-1347      
Principal Investigator: Derrick S. Haslem         
Logan Regional Hospital Suspended
Logan, Utah, United States, 84321
Intermountain Medical Center Recruiting
Murray, Utah, United States, 84107
Contact: Derrick S. Haslem    801-408-1347      
Principal Investigator: Derrick S. Haslem         
McKay-Dee Hospital Center Suspended
Ogden, Utah, United States, 84403
Utah Valley Regional Medical Center Suspended
Provo, Utah, United States, 84604
Dixie Medical Center Regional Cancer Center Recruiting
Saint George, Utah, United States, 84770
Contact: Derrick S. Haslem    801-408-1347      
Principal Investigator: Derrick S. Haslem         
Utah Cancer Specialists-Salt Lake City Suspended
Salt Lake City, Utah, United States, 84106
Huntsman Cancer Institute/University of Utah Suspended
Salt Lake City, Utah, United States, 84112
LDS Hospital Suspended
Salt Lake City, Utah, United States, 84143
United States, Vermont
Central Vermont Medical Center/National Life Cancer Treatment Recruiting
Berlin, Vermont, United States, 05602
Contact: Edmund Folefac    802-656-4101      
Principal Investigator: Edmund Folefac         
University of Vermont Medical Center Recruiting
Burlington, Vermont, United States, 05401
Contact: Edmund Folefac    802-656-4101      
Principal Investigator: Edmund Folefac         
University of Vermont College of Medicine Recruiting
Burlington, Vermont, United States, 05405
Contact: Edmund Folefac    802-656-4101      
Principal Investigator: Edmund Folefac         
United States, Virginia
University of Virginia Cancer Center Recruiting
Charlottesville, Virginia, United States, 22908
Contact: Ryan D. Gentzler    434-243-6322    JME3D@hscmail.mcc.virginia.edu   
Principal Investigator: Ryan D. Gentzler         
Hematology Oncology Associates of Fredericksburg Inc Suspended
Fredericksburg, Virginia, United States, 22408
Lynchburg Hematology-Oncology Clinic Suspended
Lynchburg, Virginia, United States, 24501
Memorial Hospital Of Martinsville Recruiting
Martinsville, Virginia, United States, 24115
Contact: Sreedhar Katragadda    276-666-7827      
Principal Investigator: Sreedhar Katragadda         
Bon Secours Memorial Regional Medical Center Recruiting
Mechanicsville, Virginia, United States, 23116
Contact: William J. Irvin    877-668-0683    cancerclinicaltrials@med.unc.edu   
Principal Investigator: William J. Irvin         
Bon Secours Saint Francis Medical Center Recruiting
Midlothian, Virginia, United States, 23114
Contact: William J. Irvin    877-668-0683    cancerclinicaltrials@med.unc.edu   
Principal Investigator: William J. Irvin         
Bon Secours Saint Mary's Hospital Recruiting
Richmond, Virginia, United States, 23226
Contact: William J. Irvin    877-668-0683    cancerclinicaltrials@med.unc.edu   
Principal Investigator: William J. Irvin         
Virginia Cancer Institute Recruiting
Richmond, Virginia, United States, 23230
Contact: Sarah W. Gordon    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Sarah W. Gordon         
Virginia Commonwealth University/Massey Cancer Center Recruiting
Richmond, Virginia, United States, 23298
Contact: Sarah W. Gordon    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Sarah W. Gordon         
VCU Community Memorial Health Center Suspended
South Hill, Virginia, United States, 23970
Shenandoah Oncology Associates PC Suspended
Winchester, Virginia, United States, 22601
United States, Washington
MultiCare Auburn Medical Center Recruiting
Auburn, Washington, United States, 98001
Contact: John A. Keech    907-458-5380      
Principal Investigator: John A. Keech         
Overlake Hospital Medical Center Recruiting
Bellevue, Washington, United States, 98004
Contact: John A. Keech    907-458-5380      
Principal Investigator: John A. Keech         
PeaceHealth Saint Joseph Medical Center Recruiting
Bellingham, Washington, United States, 98225
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Harrison HealthPartners Hematology and Oncology-Bremerton Suspended
Bremerton, Washington, United States, 98310
Harrison Medical Center Suspended
Bremerton, Washington, United States, 98310
Highline Medical Center-Main Campus Suspended
Burien, Washington, United States, 98166
Swedish Medical Center-Edmonds Recruiting
Edmonds, Washington, United States, 98026
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Providence Regional Cancer Partnership Suspended
Everett, Washington, United States, 98201
Tacoma/Valley Radiation Oncology Centers-Gig Harbor Recruiting
Gig Harbor, Washington, United States, 98332
Contact: John A. Keech    907-458-5380      
Principal Investigator: John A. Keech         
MultiCare Gig Harbor Medical Park Recruiting
Gig Harbor, Washington, United States, 98335
Contact: John A. Keech    907-458-5380      
Principal Investigator: John A. Keech         
Swedish Cancer Institute-Issaquah Recruiting
Issaquah, Washington, United States, 98029
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Kadlec Clinic Hematology and Oncology Recruiting
Kennewick, Washington, United States, 99336
Contact: Christina S. Baik    800-422-6237      
Principal Investigator: Christina S. Baik         
Northwest Cancer Clinic Recruiting
Kennewick, Washington, United States, 99336
Contact: John A. Keech    907-458-5380      
Principal Investigator: John A. Keech         
Seattle Cancer Care Alliance at EvergreenHealth Recruiting
Kirkland, Washington, United States, 98034
Contact: Christina S. Baik    800-422-6237      
Principal Investigator: Christina S. Baik         
PeaceHealth Saint John Medical Center Recruiting
Longview, Washington, United States, 98632
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Skagit Valley Hospital Regional Cancer Care Center Recruiting
Mount Vernon, Washington, United States, 98273
Contact: Christina S. Baik    800-422-6237      
Principal Investigator: Christina S. Baik         
Skagit Valley Hospital Recruiting
Mount Vernon, Washington, United States, 98274
Contact: Christina S. Baik    800-422-6237      
Principal Investigator: Christina S. Baik         
Jefferson Healthcare Recruiting
Port Townsend, Washington, United States, 98368
Contact: John A. Keech    907-458-5380      
Principal Investigator: John A. Keech         
Harrison HealthPartners Hematology and Oncology-Poulsbo Suspended
Poulsbo, Washington, United States, 98370
Peninsula Cancer Center Suspended
Poulsbo, Washington, United States, 98370
MultiCare Good Samaritan Hospital Recruiting
Puyallup, Washington, United States, 98372
Contact: John A. Keech    907-458-5380      
Principal Investigator: John A. Keech         
Tacoma/Valley Radiation Oncology Centers-Puyallup Recruiting
Puyallup, Washington, United States, 98372
Contact: John A. Keech    907-458-5380      
Principal Investigator: John A. Keech         
Virginia Mason Medical Center Suspended
Seattle, Washington, United States, 98101
Swedish Medical Center-Ballard Campus Recruiting
Seattle, Washington, United States, 98107
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Fred Hutchinson Cancer Research Center Recruiting
Seattle, Washington, United States, 98109
Contact: Christina S. Baik    800-422-6237      
Principal Investigator: Christina S. Baik         
Seattle Cancer Care Alliance Recruiting
Seattle, Washington, United States, 98109
Contact: Christina S. Baik    800-422-6237      
Principal Investigator: Christina S. Baik         
Kaiser Permanente Washington Suspended
Seattle, Washington, United States, 98112
Swedish Medical Center-First Hill Recruiting
Seattle, Washington, United States, 98122-4307
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Seattle Cancer Care Alliance at Northwest Hospital Recruiting
Seattle, Washington, United States, 98133
Contact: Christina S. Baik    800-422-6237      
Principal Investigator: Christina S. Baik         
University of Washington Medical Center Recruiting
Seattle, Washington, United States, 98195
Contact: Christina S. Baik    800-422-6237      
Principal Investigator: Christina S. Baik         
Tacoma/Valley Radiation Oncology Centers-Jackson Hall Suspended
Tacoma, Washington, United States, 97405
Franciscan Research Center-Northwest Medical Plaza Suspended
Tacoma, Washington, United States, 98405
MultiCare Tacoma General Hospital Recruiting
Tacoma, Washington, United States, 98405
Contact: John A. Keech    907-458-5380      
Principal Investigator: John A. Keech         
Northwest Medical Specialties PLLC Suspended
Tacoma, Washington, United States, 98405
Northwest NCI Community Oncology Research Program Suspended
Tacoma, Washington, United States, 98405
Saint Joseph Medical Center Suspended
Tacoma, Washington, United States, 98405
Tacoma/Valley Radiation Oncology Centers-Saint Joe's Suspended
Tacoma, Washington, United States, 98405
PeaceHealth Southwest Medical Center Recruiting
Vancouver, Washington, United States, 98664
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Legacy Salmon Creek Hospital Recruiting
Vancouver, Washington, United States, 98686
Contact: Jacqueline Vuky    503-413-1742      
Principal Investigator: Jacqueline Vuky         
Providence Saint Mary Regional Cancer Center Recruiting
Walla Walla, Washington, United States, 99362
Contact: Gary E. Goodman    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Gary E. Goodman         
Wenatchee Valley Hospital and Clinics Recruiting
Wenatchee, Washington, United States, 98801
Contact: Christina S. Baik    800-422-6237      
Principal Investigator: Christina S. Baik         
United States, West Virginia
United Hospital Center Suspended
Bridgeport, West Virginia, United States, 26330
West Virginia University Charleston Recruiting
Charleston, West Virginia, United States, 25304
Contact: Steven J. Jubelirer    304-388-9944      
Principal Investigator: Steven J. Jubelirer         
Edwards Comprehensive Cancer Center Suspended
Huntington, West Virginia, United States, 25701
Saint Mary's Medical Center Recruiting
Huntington, West Virginia, United States, 25702
Contact: Arvinder S. Bir    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Arvinder S. Bir         
West Virginia University Healthcare Recruiting
Morgantown, West Virginia, United States, 26506
Contact: Patrick C. Ma    866-223-8100      
Principal Investigator: Patrick C. Ma         
Camden-Clark Memorial Hospital Recruiting
Parkersburg, West Virginia, United States, 26101
Contact: Patrick C. Ma    866-223-8100      
Principal Investigator: Patrick C. Ma         
United States, Wisconsin
Langlade Hospital and Cancer Center Suspended
Antigo, Wisconsin, United States, 54409
Fox Valley Hematology and Oncology SC-Appleton Suspended
Appleton, Wisconsin, United States, 54913
Aurora Cancer Care-Southern Lakes VLCC Recruiting
Burlington, Wisconsin, United States, 53105
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Marshfield Clinic-Chippewa Center Recruiting
Chippewa Falls, Wisconsin, United States, 54729
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
Marshfield Clinic Cancer Center at Sacred Heart Recruiting
Eau Claire, Wisconsin, United States, 54701
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
Sacred Heart Hospital Recruiting
Eau Claire, Wisconsin, United States, 54701
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
Aurora Health Center-Fond du Lac Recruiting
Fond Du Lac, Wisconsin, United States, 54937
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Aurora Health Care Germantown Health Center Recruiting
Germantown, Wisconsin, United States, 53022
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Aurora Cancer Care-Grafton Recruiting
Grafton, Wisconsin, United States, 53024
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Green Bay Oncology at Saint Vincent Hospital Recruiting
Green Bay, Wisconsin, United States, 54301-3526
Contact: Matthew L. Ryan    920-433-8889      
Principal Investigator: Matthew L. Ryan         
Saint Vincent Hospital Cancer Center Green Bay Recruiting
Green Bay, Wisconsin, United States, 54301
Contact: Matthew L. Ryan    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Matthew L. Ryan         
Green Bay Oncology Limited at Saint Mary's Hospital Suspended
Green Bay, Wisconsin, United States, 54303
Saint Vincent Hospital Cancer Center at Saint Mary's Recruiting
Green Bay, Wisconsin, United States, 54303
Contact: Matthew L. Ryan    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Matthew L. Ryan         
Aurora BayCare Medical Center Recruiting
Green Bay, Wisconsin, United States, 54311
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Mercy Health System Recruiting
Janesville, Wisconsin, United States, 53547
Contact: Emily G. Robinson    800-928-1103      
Principal Investigator: Emily G. Robinson         
UW Cancer Center Johnson Creek Recruiting
Johnson Creek, Wisconsin, United States, 53038
Contact: Anne M. Traynor    608-256-1901 ext 17007      
Principal Investigator: Anne M. Traynor         
Aurora Cancer Care-Kenosha South Recruiting
Kenosha, Wisconsin, United States, 53142
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Gundersen Lutheran Medical Center Recruiting
La Crosse, Wisconsin, United States, 54601
Contact: Kurt Oettel    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Kurt Oettel         
Marshfield Clinic - Ladysmith Center Recruiting
Ladysmith, Wisconsin, United States, 54848
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
University of Wisconsin Hospital and Clinics Recruiting
Madison, Wisconsin, United States, 53792
Contact: Anne M. Traynor    608-256-1901 ext 17007      
Principal Investigator: Anne M. Traynor         
Holy Family Memorial Hospital Recruiting
Manitowoc, Wisconsin, United States, 54221
Contact: Matthew L. Ryan    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Matthew L. Ryan         
Aurora Bay Area Medical Group-Marinette Recruiting
Marinette, Wisconsin, United States, 54143
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Vince Lombardi Cancer Clinic-Marinette Recruiting
Marinette, Wisconsin, United States, 54143
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Marshfield Clinic Recruiting
Marshfield, Wisconsin, United States, 54449
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
Marshfield Medical Center Recruiting
Marshfield, Wisconsin, United States, 54449
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
Community Memorial Hospital Suspended
Menomonee Falls, Wisconsin, United States, 53051
Aurora Cancer Care-Milwaukee Recruiting
Milwaukee, Wisconsin, United States, 53209
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Aurora Saint Luke's Medical Center Recruiting
Milwaukee, Wisconsin, United States, 53215
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Froedtert and the Medical College of Wisconsin Recruiting
Milwaukee, Wisconsin, United States, 53226
Contact: Smitha P. Menon    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: Smitha P. Menon         
Aurora Sinai Medical Center Recruiting
Milwaukee, Wisconsin, United States, 53233
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Marshfield Clinic-Minocqua Center Recruiting
Minocqua, Wisconsin, United States, 54548
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
ProHealth D N Greenwald Center Suspended
Mukwonago, Wisconsin, United States, 53149
Cancer Center of Western Wisconsin Suspended
New Richmond, Wisconsin, United States, 54017
ProHealth Oconomowoc Memorial Hospital Suspended
Oconomowoc, Wisconsin, United States, 53066
Green Bay Oncology - Oconto Falls Recruiting
Oconto Falls, Wisconsin, United States, 54154
Contact: Matthew L. Ryan    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Matthew L. Ryan         
Vince Lombardi Cancer Clinic - Oshkosh Recruiting
Oshkosh, Wisconsin, United States, 54904
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Aurora Cancer Care-Racine Recruiting
Racine, Wisconsin, United States, 53406
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Marshfield Clinic at James Beck Cancer Center Suspended
Rhinelander, Wisconsin, United States, 54501
Saint Mary's Hospital Suspended
Rhinelander, Wisconsin, United States, 54501
Lakeview Medical Center-Marshfield Clinic Suspended
Rice Lake, Wisconsin, United States, 54868
Marshfield Clinic-Rice Lake Center Recruiting
Rice Lake, Wisconsin, United States, 54868
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
Vince Lombardi Cancer Clinic-Sheboygan Recruiting
Sheboygan, Wisconsin, United States, 53081
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Marshfield Clinic Cancer Care at Saint Michael's Hospital Suspended
Stevens Point, Wisconsin, United States, 54481
Saint Michael's Hospital Suspended
Stevens Point, Wisconsin, United States, 54481
Marshfield Clinic Stevens Point Center Recruiting
Stevens Point, Wisconsin, United States, 54482
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
Saint Vincent Hospital Cancer Center at Sturgeon Bay Recruiting
Sturgeon Bay, Wisconsin, United States, 54235-1495
Contact: Matthew L. Ryan    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Matthew L. Ryan         
Green Bay Oncology - Sturgeon Bay Suspended
Sturgeon Bay, Wisconsin, United States, 54235
Aurora Medical Center in Summit Recruiting
Summit, Wisconsin, United States, 53066
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Vince Lombardi Cancer Clinic-Two Rivers Suspended
Two Rivers, Wisconsin, United States, 54241
Aurora Cancer Care-Waukesha Suspended
Waukesha, Wisconsin, United States, 53188
ProHealth Waukesha Memorial Hospital Suspended
Waukesha, Wisconsin, United States, 53188
UW Cancer Center at ProHealth Care Suspended
Waukesha, Wisconsin, United States, 53188
Aspirus Regional Cancer Center Suspended
Wausau, Wisconsin, United States, 54401
Marshfield Clinic-Wausau Center Recruiting
Wausau, Wisconsin, United States, 54401
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
Aurora Cancer Care-Milwaukee West Recruiting
Wauwatosa, Wisconsin, United States, 53226
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
Aurora West Allis Medical Center Recruiting
West Allis, Wisconsin, United States, 53227
Contact: Rubina Qamar    414-649-5717      
Principal Investigator: Rubina Qamar         
The Alyce and Elmore Kraemer Cancer Care Center Suspended
West Bend, Wisconsin, United States, 53095
Diagnostic and Treatment Center Recruiting
Weston, Wisconsin, United States, 54476
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
Marshfield Clinic - Weston Center Recruiting
Weston, Wisconsin, United States, 54476
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
Saint Clare's Hospital Suspended
Weston, Wisconsin, United States, 54476
Aspirus UW Cancer Center Recruiting
Wisconsin Rapids, Wisconsin, United States, 54494
Contact: Harish G. Ahuja    877-405-6866      
Principal Investigator: Harish G. Ahuja         
Marshfield Clinic - Wisconsin Rapids Center Recruiting
Wisconsin Rapids, Wisconsin, United States, 54494
Contact: Adedayo A. Onitilo    800-347-0673      
Principal Investigator: Adedayo A. Onitilo         
United States, Wyoming
Rocky Mountain Oncology Suspended
Casper, Wyoming, United States, 82609
Big Horn Basin Cancer Center Suspended
Cody, Wyoming, United States, 82414
Billings Clinic-Cody Recruiting
Cody, Wyoming, United States, 82414
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Welch Cancer Center Recruiting
Sheridan, Wyoming, United States, 82801
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Canada, Ontario
Juravinski Cancer Centre at Hamilton Health Sciences Recruiting
Hamilton, Ontario, Canada, L8V 5C2
Contact: Peter M. Ellis    905-387-9495      
Principal Investigator: Peter M. Ellis         
Ottawa Hospital and Cancer Center-General Campus Recruiting
Ottawa, Ontario, Canada, K1H 8L6
Contact: Stephanie Y. Brule    613-761-4395      
Principal Investigator: Stephanie Y. Brule         
University Health Network-Princess Margaret Hospital Recruiting
Toronto, Ontario, Canada, M5G 2M9
Contact: Natasha B. Leighl    416-946-4501    clinical.trials@uhn.on.ca   
Principal Investigator: Natasha B. Leighl         
Canada, Saskatchewan
Allan Blair Cancer Centre Recruiting
Regina, Saskatchewan, Canada, S4T 7T1
Contact: Mussawar Iqbal    306-766-2213      
Principal Investigator: Mussawar Iqbal         
Sponsors and Collaborators
Southwest Oncology Group
National Cancer Institute (NCI)
Investigators
Principal Investigator: Vassiliki Papadimitrakopoulou Southwest Oncology Group
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Southwest Oncology Group
ClinicalTrials.gov Identifier: NCT02154490     History of Changes
Other Study ID Numbers: S1400
NCI-2014-00627 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )
S1400A
S1400E
S1400I
S1400C
S1400D
S1400B
S1400 ( Other Identifier: SWOG )
S1400 ( Other Identifier: CTEP )
U10CA180888 ( U.S. NIH Grant/Contract )
First Submitted: May 30, 2014
First Posted: June 3, 2014
Last Update Posted: November 24, 2017
Last Verified: November 2017

Product Manufactured in and Exported from the U.S.: Yes

Additional relevant MeSH terms:
Carcinoma
Lung Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases
Docetaxel
Nivolumab
Palbociclib
Tremelimumab
Talazoparib
Erlotinib Hydrochloride
Antibodies
Immunoglobulins
Antibodies, Monoclonal
Immunoglobulin G
Antineoplastic Agents
Tubulin Modulators
Antimitotic Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Immunologic Factors
Physiological Effects of Drugs
Protein Kinase Inhibitors
Enzyme Inhibitors
Poly(ADP-ribose) Polymerase Inhibitors